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Abstract 
In recent years the effectiveness of skills-training, the mainstay behavioural treatment 
for smoking-cessation, has been questioned, providing a rationale to investigate alternative 
treatments. 
We hypothesised that mindfulness, an emerging treatment for addiction, can reduce 
smoking by decreasing drug-related processing bias and remediating deficits in inhibitory 
control. Our study tested this in 37 smokers and 12 non-smokers at baseline, and at a 1–2 
month follow-up after smokers used a 22-day long mindfulness-based smoking-cessation 
programme called Craving to Quit (C2Q), which was delivered via smartphone. Poor 
inhibitory control was defined as lower accuracy and lower amplitudes of the event-related 
potentials (ERPs), N2 and P3, elicited in a Go/NoGo task. Drug-related processing bias was 
defined as higher P3 and late positive potential (LPP) ERP amplitudes elicited for smoking 
images relative to neutral images, during an image slideshow task. The task also expected to 
show normal responding to pleasant and unpleasant images in smokers, shown by increased 
P3 and LPP amplitudes, compared to neutral images.  
The study replicated a deficit in inhibitory control among smokers (reduced NoGo 
N2) but found no smoking-related processing bias at baseline. Unexpectedly, the study 
revealed blunted P3 amplitudes in response to all picture categories, except unpleasant, in 
smokers at baseline. We suggest that this may be reflective of an anhedonic state during acute 
withdrawal. 
A large non-compliance rate led to a follow-up comparison limited to 11 smokers and 
11 non-smokers. Although smokers showed significant reductions in average number of 
cigarettes smoked/day, they showed no change in self-reported craving. They also showed no 
change in processing to any of the picture categories. We suggest that limitations due to 
filtering hampered our ability to detect what appeared to be an increased late LPP at frontal 
electrodes for all categories, potentially reflecting increased awareness from mindfulness. 
Although smokers showed significantly lower NoGo accuracy compared to non-smokers at 
follow-up, they also showed increases in a neural marker of inhibitory control (NoGo P3). 
Further research is required to determine whether this reflects neural improvements preceding 
changes in behaviour, or reflects a compensatory increase in neural activity during a quit 
attempt.  
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Overall, our study suggests that mindfulness-treatment can reduce smoking when 
delivered via smartphone but we cannot confirm whether this is related to mindfulness, the 
app, being in the study or a quit attempt. Further research comparing C2Q to an alternative 
intervention group, is needed to further explore C2Q’s mechanisms of action and whether it 
shows benefit over other apps.  
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1 Introduction 
1.1 Overview of drug addiction and reward 
Addiction is often described as a chronic relapsing brain disorder (Cadet, Bisagno, & 
Milroy, 2014; Kalivas & O’Brien, 2008) that can be conceptualised as a 3-stage cycle. In the 
first stage, a loss of control in regulating drug use leads to drug binging and intoxication. 
Following this is the second phase, drug withdrawal, which is characterised by negative affect 
(anhedonia). The third stage involves preoccupation and compulsions for the drug of 
addiction which ultimately leads to another binge episode (Wise & Koob, 2014). While 
addiction may begin from choice (drug experimentation), control becomes markedly 
disrupted as the disorder develops and individuals will seek drugs of abuse, even at the 
expense of serious adverse health or financial consequences (Camí & Farré, 2003; Volkow & 
Li, 2004). 
Abnormal responding of brain reward networks to drugs of abuse is likely to play a 
key role in the development and maintenance of addiction. The magnitude of dopamine (DA) 
release in the nucleus accumbens (part of the so-called “reward system”) is suggested to be at 
least 5–10 fold greater in response to drugs compared with natural reinforcers such as food 
and sex (Volkow & Li, 2004). This is also enhanced with repeated administration of drugs 
while repeated exposure to natural reinforcers leads to habituation of DA release (Vetulani, 
2001). These supraphysiological changes to the dopaminergic mesolimbic reward system 
make individuals more likely to abuse drugs and to experience unpleasant drug craving with 
withdrawal (Vetulani, 2001; Volkow & Li, 2004). 
While it is known that drugs can exacerbate DA release, the actual role of DA in 
initiation and maintenance of addiction is debated. Initial theories of drug addiction stemmed 
from early hypotheses linking DA and reward. The “anhedonia hypothesis” suggests that 
pleasure is directly mediated by DA and that blocking DA receptors would therefore block 
subjective experiences of pleasure (Wise, 1982). Following this hypothesis, other researchers 
suggested that negative emotional withdrawal states could be attributed to a hedonic 
dysregulation caused by suppressed DA neurotransmission during drug withdrawal (Koob & 
Le Moal, 2001). Drug taking is then reinforced by a drive to re-establish hedonic homeostasis.  
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Following R. A. Wise (1982), newer research has surfaced which questions the 
anhedonia hypothesis and its related theories of addiction. It is now believed that the 
involvement of DA in addiction is more related to anticipation of drug taking than the actual 
consumption (Berridge & Robinson, 1998; Chiara & Alan North, 1992). Support of this 
includes Berridge and Robinson’s (1998) key finding in rats, which retained the ability to 
discriminate the hedonic properties of taste stimuli, even after they were given neurochemical 
lesions to their DA mesolimbic system. This was one of the first of many studies to suggest 
that DA is not necessary for hedonic processing, and that anhedonia is not necessary for 
increased craving and the maintenance of addiction. Other studies have shown dissociations 
of pleasure and drug taking in individuals addicted to cocaine and instances where DA 
antagonists fail to reduce amphetamine-induced pleasure. In addition, discharge of DA at the 
nucleus accumbens has been observed during anticipation of reward while not during the 
actual experience of it (Robinson & Berridge, 2000). This proposed link between DA and 
drug anticipation has led to the “Incentive Salience Hypothesis.” Although incentive salience 
has been mentioned in earlier research, including Chiara & Alan North, (1992), its most well 
known documentation has been by Berridge and Robinson (1998). The incentive salience 
hypothesis separates the reward process into “wanting” and “liking” (hedonic) and asserts that 
they are mediated by different neural systems. Together, wanting and liking form “incentive 
salience,” which describes the associations that change a neutral conditioned stimulus into an 
attractive and wanted incentive that can grab the attention. An important part of the incentive 
salience hypothesis is that DA systems are only necessary for attributing incentive salience to 
the drug of addiction and not necessary for hedonic processing as hypothesised by R. A. Wise 
(1982). 
An alternative but complementary theory to the incentive salience hypothesis, is that 
proposed by Everitt & Robbins (2005). They suggested that drug taking is initially reinforced 
through instrumental learning of associations between actions (drug taking) and outcomes 
(drug effects). As addiction develops, environmental stimuli that are repeatedly paired with 
drug use (e.g., drug paraphernalia) can then act as triggers for consolidated drug seeking and 
drug taking actions. This occurs via the process of Pavlovian conditioning, which underlies 
the transit from controlled drug taking to uncontrollable drug habits (Everitt & Robbins, 
2005).  
Brewer and colleagues extended on these theories and formulated the 
“addictive loop” model for nicotine dependence (Brewer, Elwafi, & Davis, 2013). In this 
loop, stimulus-response associations are expanded, suggesting that both interoceptive (affect) 
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and exteroceptive (situation) cues can lead to increased drug craving and drug-use. In 
addition, these exteroceptive cues are not always explicitly drug-related. In examples by 
Brewer and colleagues eating a tasty meal (situation) can make an individual feel happy 
(affect) which can trigger a drug craving and drug use. Likewise, a boss yelling at someone 
(situation) can make that person feel stressed (affect) which can trigger drug craving and 
drug-use (Brewer et al., 2013). In addition to habits being maintained by incentive salience, 
they can also be maintained through operant conditioning. Through operant conditioning a 
positive memory formed after drug-use can reinforce an affect that was elicited by the same 
environmental cue that gains incentive salience, such as the memory of feeling better after 
drug use will increase incentive salience of the associated environmental cue, and negatively 
reinforce unpleasant affects associated with that cue. Likewise, positive reinforcement will 
occur for drug-use following a positive affect. This reinforcement then strengthens the 
association between drug-use and feeling better (Brewer et al., 2013).  
Development of incentive salience for drugs of addiction and drug-related stimuli 
increases motivation for drug-use and facilitate the drug-seeking behaviour that is 
characteristic of addiction. Because of this, treatments for drug addiction should theoretically 
work by breaking down incentive salience within the addictive loop. 
1.2 Nicotine addiction: a public health concern 
The addictive potential of nicotine is well-documented. Although increased 
regulations restrict its use in public places, it is currently legal in New Zealand and most other 
countries around the world. As with other drugs of addiction, chronic use of nicotine is 
associated with perturbations to the brain reward system and increased drug-incentive 
salience. Its pleasurable psychoactive effects include arousal, relaxation, and improved mood, 
which can be attributed to its binding of nicotinic receptors, leading to the release of a number 
of neurotransmitters including, including monoamines, serotonin, acetylcholine, 𝛾-­‐
aminobutyric acid (GABA), glutamate, and endorphins (Benowitz, 2008).  
Up until mid-1960s there was little information regarding the impact of nicotine on 
health. Because of this, nicotine was regarded as fairly harmless, with about half of the 
American adult population smoking tobacco in 1965 (American Lung Association, 2011). 
Today, nicotine is recognised as the leading cause of preventable death, worldwide (Cahill, 
Stevens, Perera, & Lancaster, 2013). Cigarette smoking is estimated to kill half its users 
through respiratory diseases, cancers, and cardiovascular disease (Hoffman & Tan, 2015). 
	   5	  
After news of tobacco’s associated health risks became public in 1964, a steep decline in 
smoking rates followed (Henningfield, 2014). Despite this initial decline, in the last 3 years 
New Zealand has seen only a modest reduction of 3% with the adult daily smoking rate at 
around 15.5% (New Zealand Ministry of Health, 2014). This is far from New Zealand’s goal 
of being smoke-free by 2025 (Ministry of Health NZ, 2011). In the United States over 65% of 
smokers want to quit annually but less than 10% achieve at least 6 months of abstinence 
(Centers for Disease Control, 2011). In addition, many smokers cannot easily quit in spite of 
these health risks (Fagerstrom, Heatherton, & Kozlowski, 1990). Havik & Maeland (1988) 
found that even after experiencing a heart attack, around 40% of smokers resumed smoking 
within 6 months. Similar results were observed in smokers following lung cancer surgery 
(Walker et al., 2006). It has been estimated that it takes an average of 3–4 quit attempts before 
an individual succeeds in quitting smoking (Raw, McNeill, & West, 1998). As well as 
highlighting nicotine’s addictive potential, these statistics demonstrate the refractory nature of 
nicotine addiction and suggest a need for a new and accessible mainstay treatment for 
smoking-cessation. In searching for new mainstay treatment, both current pharmacological 
and current psychological interventions should be investigated for efficacy, accessibility and 
ability to be distributed cost-effectively, on a large scale. This is an important factor in 
achieving the goal of a smoke-free nation by 2025. In addition, the new mainstay treatment 
should show theoretical effectiveness in breaking down drug-incentive salience, and addiction 
habits, which are the proposed core of addiction.  
1.3 Pharmacological interventions 
Pharmacological agents for smoking-cessation currently approved by the U.S. Food 
and Drug Administration (FDA) include nicotine-replacement therapy (NRT), bupropion 
(Welbutrin, Zyban), and, most recently, varenicline (Champix). A recent meta-analysis has 
shown all three to be more effective than placebo with varenicline as the most effective (odds 
ratio of around 3.0) (Cahill et al., 2013). Bupropion and NRT were as effective as each other 
with an odds ratio of around 2.0; however efficacy of NRT increased to that of varenicline 
when 2 sources were used (e.g., gum and patches).  Studies used in the above meta-analysis 
all included abstinence rates for at least 6 months follow-up from treatment initiation verified 
by 7-day point abstinence as well as levels of cotinine or expired carbon monoxide. Despite 
long-term efficacy, all of the above pharmacological agents have documented side effects, 
which may lead to users stopping treatment. Insomnia occurred in about 30–40% of patients 
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in trials of bupropion, along with dry mouth, nausea and, in some cases, seizures. Similar 
symptoms occur with NRT, as well as jaw pain and skin irritation in up to 54% of those using 
nicotine patches (Cahill et al., 2013). For varenicline, symptoms include nausea, insomnia and 
vivid dreams. Nearly 10% of participants in 2 phase-3 trials discontinued varenicline because 
of unpleasant side effects.  
In addition to unpleasant side effects, which may lead users to stop treatment, it has 
been argued that pharmacological agents for smoking-cessation are not theoretically effective 
in breaking down nicotine addiction. Without breaking down the link between conditioned 
cues and smoking-related behaviours, individuals remain vulnerable to relapse which can 
occur even years after cessation (Kalivas & O’Brien, 2008). NRT, bupropion, and varenicline 
target nicotine addiction by temporarily decreasing drug compulsions and reducing unpleasant 
withdrawal symptoms. NRT and varenicline do this by binding to nicotinic acetylcholinergic 
receptors, and bupropion by inhibiting reuptake of monoaminergic neurotransmitters. 
Although reducing withdrawal symptoms and craving can lead to less likelihood of relapse, 
these benefits cease with end of treatment. Successful interventions for relapse-prevention 
should be able to reduce these symptoms long-term so that individuals can avoid needing to 
re-experience the unpleasant side effects of pharmacological treatments. While 
pharmacological treatments may prevent further development of new stimulus associations, 
they are not capable of reversing those that are already developed (Berridge & Robinson, 
1998). Breaking down these associations are important in keeping smokers abstinent long-
term.  
1.4 Psychological interventions 
The most widely used psychosocial intervention for smoking-cessation is counselling. 
The two main features of counselling include skills-training and therapeutic support; yet other 
interventions can be used in conjunction with counselling to enhance smoking-cessation. One 
of these additional interventions is aversive smoking, which is a process whereby individuals 
inhale quick and repeated puffs of cigarette smoke until they feel physically ill and incapable 
of inhaling more. The aim of aversive smoking is to turn a previously “pleasant” stimulus into 
an aversive stimulus. As well as being physically dangerous, there is insufficient evidence to 
support its efficacy (Hajek & Stead, 2001).  
Another intervention for smoking-cessation is contingency management, which 
involves reinforcing short-term abstinence with monetary goals. Although contingency 
	   7	  
management has shown some efficacy, any improvements are unlikely to sustain after 
contingencies are discontinued (Schlam & Baker, 2013). The latest additional intervention for 
smoking-cessation is exercise. Although exercise interventions have shown promise for 
smoking-cessation when used in conjunction with counselling (Marcus et al., 2005) more 
large-scale trials are needed to make robust conclusions (Ussher, Taylor, & Faulkner, 2014). 
While there are several interventions that can be used in conjunction with smoking-
cessation counselling, the most stable and foundational component of it is skills-training. The 
first part of skills-training involves teaching individuals to identify states and situations 
associated with increased smoking urges. Individuals are then taught cognitive and 
behavioural strategies for coping with these “high risk” situations. Strategies can include 
using cognitive reappraisal to reduce craving-induced negative moods, avoiding smoking-
cues (e.g., not smoking inside and staying away from people who smoke), and distracting 
oneself from smoking-cues (e.g., using pleasant activities to distract oneself from cravings) 
(Schlam & Baker, 2013).  
In addition to skills-training, another main component of counselling is therapeutic 
support. The importance of therapeutic support is highlighted by findings of only modest 
success in individuals who are taught skills-training in the form of self-help (Lancaster & 
Stead, 2005). Somewhat surprisingly, the efficacy of therapeutic support is not dependent on 
seeing individuals face-to-face. This was shown in a recent meta-analysis that suggests 
similar abstinence rates with both face-to-face and telephone counselling (Mottillo et al., 
2009). The same review also showed little difference in success rates between individual and 
group counselling, indicating that therapeutic support is effective for smoking-cessation 
regardless of its form of delivery.  
1.4.1 Smartphones 
Over the last decade mobile phones have become increasingly useful around the world 
in providing health-related information and support, including that related to smoking-
cessation (Whittaker, Borland, et al., 2012). Smartphones have promise in being a cost-
effective way of delivering smoking-cessation treatment on a large scale. With increasing use 
of smartphones in the 21st century, this form of delivery is readily accessible to many of New 
Zealand smokers.  
Routes for mobile-phone-based smoking-cessation interventions include text 
messaging and interactive applications (apps) that can be purchased from Apple or Google 
Play Store on smartphones. Although apps can provide an easy way to access help for 
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smoking-cessation, a recent content meta-analysis showed that available apps for smoking-
cessation rarely adhere to any evidence-based theory of behavioural change. They include a 
range of components such as tracking of money savings and health benefits obtained over 
abstinence, calendars tracking target quit date, and instructions for cigarette cut-down 
(Abroms, Padmanabhan, Thaweethai, & Phillips, 2011). Although these features may be 
useful to a quit attempt, these features alone are not unlikely, at least theoretically, to promote 
behaviour change.  
Two recently developed apps for smoking-cessation are based on the social cognitive 
theory. This theory suggests that individuals can learn behaviour and cognitive skills from 
observing models and this leads individuals to imitate those behaviours (Bandura, 1997). 
These apps have an advantage over previous apps in that they were developed from an 
established theory of behavioural change. One of these apps is called STUB IT and was 
developed by The Clinical Trials Research Unit at Auckland University, New Zealand 
(Whittaker, Merry, Dorey, & Maddison, 2012). The app includes texts and videos of role 
models designed to enhance self-efficacy for quitting. This is a useful target for smoking-
cessation interventions as low self-efficacy is a risk factor for relapse (Schlam & Baker, 
2013), however, a randomized controlled trial showed that STUB IT was no more effective 
than a control group who received regular health-related text and video messages (Whittaker 
et al., 2008).  A similar app to STUB IT called REQ-mobile was also based on the social 
cognitive theory (Buller, Borland, Bettinghaus, Shane, & Zimmerman, 2014). REQ-mobile 
sends messages involving skills-training strategies and audio testimonials of ex-smokers (quit 
role models). REQ-mobile was found less effective than a simpler version of the intervention, 
consisting only of the texts of skills-training strategies. The researchers concluded that the 
audio testimonials were not useful for participants, suggesting that quit role models give little 
additional benefit to quit success over skills-training.  
Another intervention developed by Auckland University, that involves skills-training 
as well as peer and therapeutic support, is called STOMP. This was a personalized 4-week 
text-based intervention, which pulled texts from over 1000 messages (half cessation-based, 
half general interest) developed by a multidisciplinary team of young adults, Maori health 
researchers, and experts in adolescent health, nutrition, CBT, and smoking-cessation. Text 
messages were chosen for each participant based on personal preferences, smoking history, 
barriers to cessation, etc. Personal preferences were also used to pair participants of similar 
interests as quit-buddies. In a large randomised controlled trial (1705 participants), 
researchers found that significantly more participants had quit with STOMP (28%) than in the 
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control group (13%) at 6-week follow-up (Rodgers et al., 2005). The above studies suggest 
that, as with counselling, the most useful components of mobile-phone-based interventions 
for smoking-cessation are skills-training plus peer and therapeutic support.  
SmartQuit is a more recently developed smartphone app for smoking-cessation, which 
follows an alternative intervention for behaviour change called Acceptance and Commitment 
Therapy (ACT) (Bricker et al., 2014). ACT encourages individuals to increase their 
willingness to experience emotions, thoughts, and physical cravings while making committed 
and values-guided changes in behaviour. The key features in SmartQuit include the “I 
Slipped” and “Having an Urge” buttons which replace skills-training strategies for dealing 
with craving. Clicking on the above components provides the user with acceptance skills that 
can be used to cope with cravings, lapses, and the self-judgments that often accompany them. 
In a randomized control pilot trial, SmartQuit showed significantly larger quit rates (13%) to 
another app called QuitGuide (8%), based on skills-training (Bricker et al., 2014). Although 
these quit rates are small, the authors admit that the study was underpowered to detect 
differences in quit-rates and it is suggested that a full-scale efficacy trial is now needed 
(Bricker et al., 2014). Another reason for small quit rates could be because of the rigorous 30-
day point prevalence definition used for abstinence in Bricker et al. (2014). Abstinence would 
have been more difficult to achieve in this study than others, which used only a 7-day point 
prevalence definition (Rodgers et al., 2005).  
Two other apps currently being compared to each other are NCI (National Cancer 
Institute) QuitPal (QuitPal) and Craving to Quit (C2Q) (Penberthy, 2014). Both apps are 
based on evidence-based practice for smoking-cessation, including skills-training techniques 
and mindfulness, for QuitPal and C2Q, respectively. See section 1.6 for more on mindfulness 
and C2Q. 
Overall, skills-training and therapeutic support appears to be the most well studied, 
beneficial psychological treatments available for smoking-cessation. These factors are core 
components of counselling, which can be delivered with equal effectiveness individually, in a 
group, over the telephone and more recently, via smartphones. Despite support for skills-
training, recent evidence suggests that alternative interventions such as ACT may be more 
effective (Bricker et al., 2014) and that the efficacy of skills-training may be declining. A 
recent analysis of clinical trials that used skill training for smoking-cessation suggest that as 
smoking prevalence has declined, the remaining treatment-seeking smokers have become 
difficult to treat (Irvin & Brandon, 2000). In addition to this, a skills-training based smoking-
cessation service in NZ called “Quitline,” shows room to improve with a quit rate of only 
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24% (Gravitas, 2012). Because Quitline is the national government-supported service for 
smoking-cessation in NZ, it is important that it provides the most effective and up-to-date 
techniques for aiding smoking-cessation. 
In addition to declining efficacy, some researchers suggest that skills-training has 
limited effectiveness because it fails to target the core problem of addiction (Brewer et al., 
2011). As with pharmacotherapy, distraction and avoidance techniques are theoretically 
incapable of breaking down incentive salience attributions, but may be effective at reducing 
craving thus facilitating psychological interventions. Without breaking down these 
attributions, individuals remain vulnerable to relapse. With the goal of a smoke-free nation by 
2025, New Zealand is in need of an alternative mainstay treatment for nicotine-cessation, 
protecting against relapse. In order to find such a treatment, neurobiological and 
psychological abnormalities associated with addiction should be studied. One can then 
hypothesise which and how alternative treatments will work. 
1.5 Identifying deficits that maintain smoking addiction 
Two neurobiological and psychological abnormalities that have been consistently 
shown in addiction are impaired inhibitory control and abnormal processing of drug-related 
and affective stimuli. Normalising these two processes may dismantle previous maladaptive 
associations and prevent against relapse. 
1.5.1 Image processing bias 
1.5.1.1 Behavioural measures 
Individuals with addiction often exhibit an attentional bias. This describes an 
automatic tendency to increase attendance and processing of substance-related cues (Littel & 
Franken, 2011). Behavioural paradigms used to elicit attentional bias usually involve 
measuring a participant’s performance on a simple cognitive task (e.g., sustained attention). 
Attentional bias is inferred when task performance is impaired during the presence of 
substance-related cues (e.g., image of a cigarette) compared to neutral cues (M. Field, 
Munafò, & Franken, 2009). Impaired performance during substance-related cues has been 
shown for a range of addictions including alcohol (Lusher, Chandler, & Ball, 2004), cannabis 
(Cousijn, Watson, Koenders, Vingerhoets, Goudriaan, & Wiers, 2013), heroin (Franken, 
Kroon, Wiers, & Jansen, 2000), cocaine (Hester, Dixon, & Garavan, 2006), ecstasy (Roberts 
& Garavan, 2013), and nicotine (Grundey et al., 2015). 
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1.5.1.2 Neural measures 
Another way to measure drug-related attentional bias is by recording event-related 
potentials (ERPs) including the P3 component (also called the P300 component) and late 
positive potential (LPP) during passive viewing of substance-related images. The P3 is a large 
positive deflection peaking at approximately 300 ms after stimulus onset (Sutton, Braren, 
Zubin, & John, 1965). The P3 is typically recorded between 270–600 ms after stimulus onset 
at frontal–parietal electrodes (Asmaro, Carolan, & Liotti, 2014; Engelmann, Gewirtz, & 
Cuthbert, 2011; Fehr, Wiedenmann, & Herrmann, 2006; Han et al., 2014; Jang, Lee, Yang, & 
Lee, 2007; Juckel et al., 2012; Littel & Franken, 2007; Lubman, Allen, Peters, & Deakin, 
2007; Sarlo, Übel, Leutgeb, & Schienle, 2013; van Dinteren, Arns, Jongsma, & Kessels, 
2014). The P3 has been traditionally studied using oddball paradigms in which it is enhanced 
for infrequent target stimuli. Because of this it is believed to reflect deployment of attentional 
resources to target-relevant stimuli and, more recently, to motivationally salient stimuli that 
are also “target-relevant.” In healthy individuals, the P3 is enhanced for pleasant and 
unpleasant stimuli relative to neutral, also for threat stimuli in people with generalized anxiety 
disorder (Han, Gan, Li, Li, Guo, & Yao, 2014), food stimuli in fasting individuals (Baldeweg, 
Ullsperger, Pietrowsky, Fehm, & Born, 1993), and substance-related stimuli in drug 
addiction: cannabis (Asmaro et al., 2014), alcohol (Namkoong, Lee, Lee, Lee, & An, 2004), 
opiates (Lubman et al., 2007), and nicotine (Littel & Franken, 2007; McDonough & Warren, 
2001; Versace et al., 2011). 
The LPP is another positive component related to processing of motivationally salient 
stimuli, which occurs from about 400 ms and lasts up to several seconds after stimulus 
presentation. Like the P3, the LPP is reliably enhanced following presentation of pleasant and 
unpleasant images compared to neutral ones (Foti, Hajcak, & Dien, 2009) and for substance-
related stimuli in addicted populations (Dunning et al., 2011; Littel & Franken, 2011). 
Differentiation between the P3 component and the LPP can be difficult, which may be largely 
in part due to the overlapping time-windows that are used to define them. It is often the case 
that one study will use the same time window to define LPP as has been used in another study 
to define the P3 (Hajcak, MacNamara, & Olvet, 2010). Using temporal-spatial principal 
component analysis (PCA) Foti et al., (2009) suggested a separation within the LPP 
component and possibly a separation of the P3 from the late portion of the LPP. The initial 
portion of the LPP (300–600 ms) is considered to be consistent with the P3, while the later 
portion (> 600 ms) reflects additional processes relevant for emotional processing. In addition 
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to this, LPP appears to shift from parietal to more frontal sites within 1–2 s after stimulus 
onset (Foti et al., 2009). While the P3 and early part of LPP component appear to be similar, 
the P3 is a more transient potential, generally measured as peak amplitude (Littel et al., 2011). 
In contrast, the LPP is a more sustained potential that is measured as average amplitude 
within a 250–1000 ms time-window between 400–2000 ms after stimulus onset. Because of 
this, the P3 and LPP components cannot be thought of as identical and it is suggested that 
while the P3 reflects initial allocation of attentional resources to motivationally-salient 
stimuli, the LPP may reflect more additional and continued processing involving memory 
encoding and storage (Littel & Franken, 2011).  
An enhanced P3 amplitude can therefore be considered to reflect an attentional/initial 
image processing bias while an enhanced LPP amplitude can be considered to reflect a 
continued image processing bias. Both of these can then be interpreted under the term, “image 
processing bias.” Figure 1.1 shows a schematic of a typical ERP waveform elicited by an 
image slideshow. This was taken, and adapted from Littel & Franken (2011). 
Additional information in defining the P3 and LPP can be achieved by looking at their 
location. ERPs do not indicate the exact location of the P3 and LPP but previous studies 
recording simultaneous functional magnetic resonance imaging (fMRI) and 
electroencephalograph (EEG) provide suggestions. Liu and co-workers found that among 
healthy participants viewing pleasant images, LPP was coupled with blood oxygen level-
dependent (BOLD) activity in emotion-processing structures including the amygdala and 
prefrontal cortex (PFC) (Liu, Huang, McGinnis-Deweese, Keil, & Ding 2012). Because the 
LPP was defined as average amplitude between 300–600 ms, and was strongest among 
parietal regions, the study is likely to have inadvertently measured P3 as well. A similar study 
measured fMRI activity associated with LPP defined as average amplitude between 450—900 
ms, which by Foti et al.’s (2009) definition, overlaps the time window of both P3 and LPP. 
This study found associated activity in subcortical and corticolimbic structures including the 
nucleus accumbens, amygdala and anterior cingulate cortex (ACC) (Sabatinelli, Keil, Frank, 
& Lang, 2013). In both studies, LPP was defined at only parietal or centroparietal electrodes. 
More information regarding LPP from EEG-fMRI could be achieved by measuring responses 
at later latencies and more frontal electrodes. Perhaps a better estimate of brain regions 
associated with LPP could be achieved by defining LPP in a later time window and at anterior 
electrodes. While it is difficult to determine if each potential is related to separate brain 
regions, findings from simultaneous fMRI-EEG recording suggest involvement of cortical 
and subcortical regions with both the P3 and LPP. This supports their hypothesised 
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involvement in emotion, attention, and cognitive processing which are enhanced for drug-

















Through developing addiction, brain reward systems are suggested to become 
“hypersensitive” to stimuli that have been attributed with incentive salience (Berridge & 
Robinson, 1998). In addition to the drug, itself, incentive salience can also develop for drug-
related environmental stimuli (e.g., drug paraphernalia) through Pavlovian conditioning 
involving repeated associations of environment and drug-use. The P3 and LPP could therefore 
represent useful neural markers of incentive salience for drugs and drug-related stimuli. 
Supporting the usefulness of measuring P3 and LPP in addiction are studies correlating drug-
related image processing bias with key behavioural outcomes in addiction. Both behavioural 
and neural indicators of increased image processing bias to smoking cues has been related to 
increased self-reported craving (Littel & Franken, 2007, 2011) and increased likelihood of a 
short-term lapse (Janes, Pizzagalli, Richardt, Frederick, Chuzi, Pachas, Culhane, Holmes, 
Figure 1.1. ERPs of smokers in response to neutral and smoking images (see key) at FZ, CZ, 
and PZ. Yellow rectangles depict the P3 time-window (300–500 ms). Left, grey-boarded 
rectangles depict the early LPP time window (600–1000 ms) and those on the right depict the 
late LPP time window (1000–2000 ms) (adapted from Littel & Franken, 2011). 
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Fava, Evins, & Kaufman 2010; Waters, Shiffman, & Sayette, 2003) while decreased 
smoking-related image processing bias may relate to success in long-term abstinence. Nestor, 
McCabe, Jones, Clancy, & Garavan (2011) recorded fMRI activity during an image 
processing bias paradigm where participants had to indicate the colour of borders surrounding 
neutral, pleasant, or smoking images. Ex-smokers who had abstained for at least 12-months 
were shown to have significantly less activity in subcortical areas than current smokers during 
presentation of smoking images. This suggests that decreased reactivity to smoking-related 
images is related to successful smoking-cessation. In another study, ex-smokers, compared to 
current smokers, showed smaller peak P3 and smaller mean amplitude between 500–750 ms 
during a visual slideshow of smoking-related cues. Amplitudes of ex-smokers were as low as 
those observed in never-smokers (Littel & Franken, 2007). Longitudinal studies would help 
indicate if these neural changes are a cause or effect of smoking cessation.  
In addition to bias for drug cues, responses to intrinsically pleasant cues (e.g., food 
and sex) may be blunted in smokers. In a study by Versace et al. (2012) smokers who showed 
a stronger bias to smoking cues (average amplitude between 400–700 ms post-stimulus) had a 
blunted response to pleasant stimuli (e.g., images of food and erotica). Individuals with a 
“blunted response” were also less likely to be abstinent at 12 and 24 weeks follow-up in a 
smoking-cessation trial. This suggests that treatment-refractory smokers are less responsive to 
intrinsically pleasant images than treatment-responsive smokers. This could be due to the 
possibility of treatment-refractory smokers being more sensitive to anhedonia during 
withdrawal than treatment-responsive smokers.  However, it does not follow that smokers are 
less responsive to intrinsically pleasant images than non-smokers. In comparison to non-
smokers, smokers showed significantly larger average amplitudes between 400–600 ms post-
stimulus in response to erotic images (Minnix et al., 2013). No significant differences were 
observed for neutral, unpleasant and low-arousal pleasant images. This suggests that smokers 
are more sensitive to highly arousing pleasant images than non-smokers. This however, is the 
only study to our knowledge that has compared smokers to non-smokers on pleasant and 
negative image categories. Therefore more research is needed to consolidate the findings of 
Minnix et al. (2013). 
A recent study showed evidence of modulating drug-image processing bias with 
behavioural manipulation. Littel & Franken (2011) showed decreased early LPP (600–1000 
ms) in response to smoking images for individuals who either imagined alternative 
interpretations of smoking images or actively focused on alternative stimuli in the smoking 
images. This study provided promise for the ability of behavioural interventions to modulate 
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drug-image processing bias. Interventions that resolve abnormalities of P3 and LPP during 
presentation of smoking-related and affective images could show efficacy for smoking-
cessation.   
1.5.2 Inhibitory control 
1.5.2.1 Measures 
In addition to abnormal processing of affective and drug-related stimuli, smokers have 
also shown deficits in markers of early inhibitory control. Inhibitory control can be defined as 
the ability to inhibit automatic but task-inappropriate behaviour (Powell, Dawkins, West, 
Powell, & Pickering, 2010) and can be measured by behavioural accuracy in a range of 
cognitive tasks. One of these tasks is called the “Go/NoGo” task in which individuals are 
required to press the spacebar in response to frequently occurring target stimuli (“Go”) and 
refrain from pressing spacebar during infrequent displays of non-target stimuli (“NoGo”). In 
addition to behavioural accuracy, two other measures of inhibitory control are ERPs called N2 
and P3.  
N2 is a negative waveform occurring anteriorly approximately 200–300 ms following 
presentation of non-target stimuli. It has been consistently related to performance on the 
Go/NoGo task (Falkenstein, Hoormann, & Hohnsbein, 1999) and is suggested to be a more 
sensitive measure of inhibitory control than task accuracy (Buzzell, Fedota, Roberts, & 
McDonald, 2014). Initially it was believed that N2 reflected “response inhibition” which 
defines the neural process of inhibiting a motor response (Jodo & Kayama, 1992). 
Nieuwenhuis, Yeung, van den Wildenberg, & Ridderinkhof (2003) challenged this definition 
by showing enhanced N2 for low frequency target stimuli as well as low-frequency non-target 
stimuli, dissociating N2 from inhibition of motor activity. Instead of response inhibition, 
Nieuwenhuis et al., (2003) suggested that N2 indicates a monitoring of response conflict 
(conflict-monitoring), which occurs when two opposing response tendencies are activated 
(e.g., Go vs. NoGo). In a recent review of ERP and fMRI measures of inhibitory control, 
Luijten et al. (2014) concluded that N2 is indicative of early cognitive processes important for 
inhibitory control rather than actual inhibition of the motor system. Consistent with previous 
studies, we will assume that reduced NoGo N2 amplitudes indicate impaired conflict-
monitoring, representing an early process important for efficient inhibitory control.  
The anatomical location of N2 was investigated by Gonzalez-Rosa et al. (2013) who 
measured ERPs inside an MRI scanner in healthy participants performing a modified version 
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of the Go/NoGo task. Results showed BOLD activations within the rostral anterior cingulate 
cortex (ACC) and pre-supplementary motor area (pre-SMA) during the NoGo N2 time frame, 
which suggests that the ACC and pre-SMA are generators of the N2. Luijten et al. (2014) 
suggested that the ACC and inferior frontal gyrus (IFG) are generators of the N2. The ACC 
and pre-SMA have been consistently related to measures of inhibitory control (Luijten et al., 
2014) and have even been specifically related to conflict monitoring (Maier & di Pellegrino, 
2012; Nachev, Wydell, O’Neill, Husain, & Kennard, 2007). Therefore the above studies add 
to the reliability of N2’s involvement in early cognitive control.  
A second ERP shown to be related to inhibitory control in the Go/NoGo task is the 
NoGo P3, which is a positive component, peaking between 300–500 ms after stimulus onset 
at central electrode sites (Luijten, Littel, & Franken, 2011). While in oddball paradigms 
increased P3 reflects responding to more “target-relevant” stimuli, in this task it supposedly 
reflects the late stage of inhibitory control. Studies show larger P3 amplitudes in tasks where 
individuals need to refrain from an overt motor response compared to refraining from a covert 
response (e.g., counting) (Smith, Jamadar, Provost, & Michie, 2013). This suggests that, 
unlike N2, P3 in the Go/NoGo task is related to actual inhibition of the motor cortex (Smith et 
al., 2013). Throughout the thesis we will refer to positive ERP activity within 300–500 ms 
after stimulus presentation as the P3. In the context of the image slideshow task this will 
reflect attentional processing, while in the Go/NoGo task it will reflect early motor inhibitory 
control.  
Figure 1.2 shows a schematic of a typical waveform elicited in a Go/NoGo task, 
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Fig. 1. Stimulus-locked, grand average ERP waveforms and topographic plots reflecting the N2 and P3 components elicited by the go/no-go task. Go and no-go ERP waveforms
(A,  C) were derived from averaging across the three electrode locations depicted with white ellipses in each topographic plot (B, D). Shaded areas (A, C) reflect the analysis
window and time period plotted in the topographic plots (B, D).
present results clarify conflicting reports [15,16] and reinforce the
notion that the N2 is a useful index of cognitive control deficits in
smokers.
Prior evidence suggests that the neural generator for the N2
component is the ACC [6,8], a structure implicated in cognitive con-
trol. Moreover, this brain region has been shown to be activated by
nicotine administration in humans [3] and morphological changes
within this region are associated with addiction more generally [1].
In addition, ACC activation is reduced in substance abusers [24,25].
In conjunction with previous electrophysiological [16] and func-
tional neuroimaging [24,25] work, the present findings illustrate
the presence of diminished ACC functioning in smokers, which is
in line with prevailing theoretical models of addiction [26].
The finding that the N2 was attenuated in the absence of sig-
nificant behavioral deficits suggests that light smokers may  be
able to rely on other compensatory mechanisms to maintain a
level of behavioral performance comparable to non-smokers [14].
Such an interpretation is in line with research showing a dissocia-
tion between ACC activation and behavioral performance measures
[10,27,28]. It is also possible these findings are indicative of the
fact that the participants did not exhibit strong signs of nicotine
dependence. However, it should be noted that although accuracy
did not differ significantly between groups, there was a rela-
tively weak statistical trend for reduced accuracy in light smokers.
Therefore, while the present study provides evidence that the N2
component provides a particularly sensitive index of the cognitive
control deficits observed in smokers, a larger sample might have
revealed that light smokers differ from non-smokers in terms of
behavioral performance.
While the N2 likely indexes disruption to ACC functioning in
light smokers, it remains unclear whether such dysfunction reflects
changes due to chronic nicotine exposure, or vulnerability to nico-
tine usage. Longitudinal studies have previously shown behavioral
deficits on executive functioning tasks to predict the initiation of
smoking or the use of other substances of abuse [29,30]. Therefore,
it is also possible that a reduction in the N2 component would have
been observed in the present sample of light-smokers even prior to
their initiation of smoking. While the present results do not permit
this conclusion, they do support the validity of the N2 in assessing
cognitive control deficits (even in a sample of light-smokers) and
suggest the need for additional longitudinal work employing this
method.
While developmental research has established a link between
behavioral measures of impaired executive functioning and the
likelihood of initiating smoking [29], an electrophysiological
marker of addiction liability may  better capture susceptibility. For
example, one might hypothesize that while behavioral methods
can be used to predict smoking initiation, the reliability of such
predictions might be improved with the complementary use of
ERPs. Further, longitudinal data may  be able to provide more direct
evidence as to whether the N2 component predicts smoking initi-
ation, or indexes neurobiological changes that result from chronic
nicotine exposure.
In contrast to Evans et al. [15], but consistent with the work
by Luijten and colleagues [16], we found no evidence of a reduced
no-go P3 in our sample of light smokers. However, this difference
might stem from the fact that Evans and colleagues [15] used a
hybrid go/no-go task, in comparison to the more traditional go/no-
go task employed in the present experiment and by Luijten et al.
[16]. The task employed by Evans and colleagues [15] can essen-
tially be characterized as a 1-back working memory task, which
would place additional load on working memory processes [15,31].
Therefore, the P3 difference identified by Evans and colleagues [15]
might point toward working memory deficits in smokers, which
have similarly been observed in relation to alcohol abuse [12]. In
addition, it should be noted that the participants used in the study
Figure 1.2. Figure of grand averaged ERPs for frontocentral cluster of electrodes in response 
to Go and NoGo stimuli in a Go/NoGo task. Grey rectangle indicates the N2, while yellow 
rectangle indicates the P3 (adapted from Buzzell et al., 2014). 
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1.5.2.2 Relevance 
Smokers have shown reduced NoGo N2 amplitudes (Luijten et al., 2011; Buzzell et 
al., 2014), and reduced NoGo P3 amplitudes and increased NoGo P3 latencies (Yin et al., 
2015), and decreased accuracy (Luijten et al., 2011; Yin et al., 2015) in the Go/NoGo task 
relative to controls. Luijten et al. (2011) showed that reduced NoGo N2 amplitude difference 
was not restricted to smoking-related images, which suggests that smokers have a generalized 
deficit in inhibitory control processes. While Buzzell et al. (2014) found reduced NoGo N2 
amplitudes in smokers; they observed no impairment in behavioural performance on the 
Go/NoGo task in smokers compared to controls. Because their sample of smokers had low 
nicotine dependence, they suggest that more significant behavioural differences may have 
occurred in a sample of moderately nicotine-dependent smokers.  
Reduced amplitudes of both NoGo N2 and P3 have also been observed in other 
impulsive populations including internet addiction disorder (Dong, Lu, Zhou, & Zhao, 2010), 
borderline personality disorder (Ruchsow et al., 2008) and violent offenders (Chen, Tien, 
Juan, Tzeng, & Hung, 2005). This suggests that low inhibitory control is related to higher 
levels of impulsivity. Because higher levels of impulsivity has shown to be related to faster 
relapsing in smokers (Doran, Spring, McChargue, Pergadia, & Richmond, 2004), NoGo N2 
and P3 amplitudes may also have the potential to predict speed to, and likelihood of a relapse. 
In support of this, ex-smokers have shown better performance in the Go/NoGo task and 
higher levels of prefrontal cortical activity during NoGo trials than current-smokers (Nestor et 
al., 2011). Because these areas included the ACC and frontal gyri, which are the suggested 
neural generators of N2, it can be hypothesised that increased NoGo N2 and perhaps P3 
would also correlate with successful abstinence. 
The above studies show that image processing bias and inhibitory control are two 
psychological and neurobiological factors that consistently show abnormalities among those 
with nicotine addiction. Furthermore, they have been related to changes in relapse, quit rates, 
long-term abstinence, and craving. Because of this, it is logical to assume that an intervention 
that could resolve these psychological and neurobiological abnormalities would also produce 
successful smoking-cessation. A relatively new intervention that has already shown success in 
quit rates and sustained abstinence is mindfulness (Brewer et al., 2011). Although not yet 
confirmed, research into mindfulness suggests that it may enhance quit rates through 
resolving abnormalities in inhibitory control and in attentional and affective processing of 
smoking-related stimuli. 
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1.6 Mindfulness: An eligible candidate for a new mainstay treatment for 
nicotine addiction 
1.6.1.1 Origins 
Mindfulness is the Western translation for the Pali term “Sati” which originated from 
Theravada Buddhism (early Buddhism). In Theravada Buddhism, Sati is the 7th step of the 
Noble eightfold Path to ending suffering and describes a deliberate awareness, where one 
keeps one’s mind alert to phenomena that affect the mind and body (Sedlmeier et al., 2012). 
Since being adopted in Western psychotherapy, the qualities of mindfulness have expanded to 
include not only awareness, but also non-judgement, acceptance, and compassion (Siegel, 
Germer, & Olendzki, 2008). Those practising mindfulness learn to focus on moment-to-
moment sensations, perceptions, emotions, and cognitions while avoiding rumination of the 
past and future (Garland & Howard, 2013). This reduces suffering and improves emotional 
regulation (Siegel et al., 2008). The process of becoming more mindful is cultivated through 
formal meditation where one focuses one’s awareness (e.g., on the physical sensations of the 
breath) in the present moment and in a nonjudgmental way. Formal practice improves ability 
of individuals to practise mindfulness “informally.” Mindful walking is an example of 
informal practice, during which one focuses on awareness of their most predominant sense 
within each moment-to-moment experience (e.g., pressure on feet, birds tweeting, leaves 
blowing).  
1.6.1.2 Application 
Mindfulness as a therapy has been tailored to different mental illnesses showing 
clinical success for chronic pain (la Cour, & Peterson, 2015), depression (Strauss, Cavanagh, 
Oliver, & Pettman, 2014), and, recently, addiction (Brewer et al., 2011). The application of 
mindfulness to aiding smoking-cessation is a relatively new and promising area of research. 
In a randomized control trial, mindfulness produced a significantly higher rate of 7-day point 
prevalence abstinence (31%) at 17-week follow-up than the Freedom From Smoking (FFS) 
(6%) intervention, a well-known skills-training counselling intervention developed by the 
American Lung Association (Brewer et al., 2011; Elwafi, Witkiewitz, Mallik, Iv, & Brewer, 
2013).  
Through mindfulness, smokers learn to observe and accept their cravings without 
acting on them. They are taught this through the use of analogies and metaphors such as “urge 
surfing.” This technique suggests that the listeners imagine their own cravings as waves.  
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They are encouraged to “ride” the waves through their natural intensity and fluctuations 
instead of resisting or giving into them (Marlatt & Gordon, 1985). This is similar to the 
acceptance strategy used in the SmartQuit app discussed above, which showed higher efficacy 
than an app based on skills-training (QuitGuide) (Bricker et al., 2014).  
In a smoking-cue exposure exercise by Bowen & Marlatt (2009), smokers were 
instructed through a set of steps, which resulted in drawing a lighter towards a cigarette in the 
mouth without igniting it. Within this exposure exercise, participants were given suggestions 
of how to cope with arising cravings. They were told either to use their “usual techniques” 
(control) or to non-judgmentally observe their thoughts and sensations and “surf” their 
cravings (mindfulness). At 24-hour and 7-day follow-up, those in the mindfulness condition 
showed a higher reduction in number of cigarettes smoked/day compared to the control 
condition. Interestingly, there was no difference in recorded urges, suggesting that 
mindfulness, at least initially, does not reduce level of urges but rather the responses to those 
urges. Elwafi et al.’s (2013) study expanded on this finding by showing that a 4-week 
mindfulness intervention decoupled the positive correlation commonly observed between 
craving and smoking. It has been suggested that breaking this link may be a critical target in 
long-term success of smoking cessation (Brewer, et al., 2013). As a result, these findings have 
contributed to the development of a smartphone application called Craving to Quit 
(https://cravingtoquit.com). This is a 22-day programme that incorporates mindfulness 
techniques and is currently being tested in 2 separate studies, against daily experience-
sampling (of craving and smoking status) (Garrison et al., 2015), and another app called 
QuitPal (http://smokefree.gov/apps-QuitPal), which is based on skills-training (University of 
Virginia, 2014). Experience-sampling is a method of collecting data at multiple time points 
across an extended testing period (e.g., > 1 week) and is useful for tracking progress during of 
after an intervention. 
Mindfulness is unlike skills-training strategies, which attempt to reduce unhelpful 
habits by cue avoidance, increasing positive affect, diverting attention, and substituting 
behaviours. Diverting attention may be unsuccessful because it requires cognitive resources, 
which can be depleted with increased negative affect (Brewer et al., 2011). Substituting 
behaviours and avoiding cues may be less successful because they do not directly dismantle 
the addictive loop and simply leave it dormant to be reactivated at another time (Brewer et al., 
2013). Mindfulness is suggested to be a more promising intervention than skills-training for 
preventing relapse as it directly dismantles the addictive loop, in part by breaking down 
unhelpful associations between affect and craving (Brewer et al., 2011). Those who practise 
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mindfulness learn to sit with and accept their cravings while not reacting to them. This avoids 
reinforcing unhelpful associations such as “I feel better when I smoke” and is likely why 
mindfulness is able to decouple the relationship between craving and smoking (Brewer et al., 
2013), and break down the persistent association between drug cues and responses. 
1.6.1.3 Neural mechanisms 
Only one study has linked mindfulness-associated smoking reduction with potential 
neurobiological mechanisms. In this study by Tang, Tang, & Posner (2013), smokers were 
randomly assigned to a 2-week meditation programme involving mindfulness or a control 
condition with relaxation training. Those in the mindfulness condition showed increased 
resting state activity in the PFC and ACC post-intervention compared to pre-intervention. In 
addition they showed significantly reduced smoking and craving. These effects were specific 
to the mindfulness condition. Because increased activity was observed in brain areas 
associated with self-control (ACC, PFC), Tang et al. (2013) suggest this is a mechanism 
through which mindfulness reduces smoking.  
Other studies have provided evidence of mindfulness increasing neural markers of 
early inhibitory control in non-smoking populations. Experienced meditators, compared to 
controls, showed increased cortical thickness of the dorsal ACC (Grant, Courtemanche, 
Duerden, Duncan, & Rainville, 2010) and even brief mindfulness training (11 hours separated 
over a month) was shown to increase fractional anisotropy on MRI (method for analysing 
integrity of white matter fibre tracts) in the corona radiata of healthy undergraduate students 
(Tang, Lu, Geng, Stein, Yang, & Posner, 2010). The corona radiata is an important white-
matter tract that connects the ACC to the striatum and other structures and is considered a key 
node of the self-regulation network (Tang et al., 2010). This network is broadly defined as the 
ability to control one’s thoughts, feelings, and behaviours (Posner, Rothbart, Sheese, & Tang, 
2007). In another study by Hölzel et al. (2007), experienced-mediators showed increased 
rostral ACC activity during mindful breathing. Hölzel et al. (2007) suggest that this reflects 
an improved ability for attention and emotion regulation. Because the rostral ACC has been 
specifically related to N2 activity (Gonzalez-Rosa et al., 2013) and to conflict-monitoring 
(Maier & di Pellegrino, 2012), mindfulness may also increase N2 amplitudes in Go/NoGo 
tasks. If mindfulness can improve inhibitory control and emotion regulation in smokers, this 
could potentially lead to better control over a smoker’s automatic tendency to smoke in 
response to craving, i.e., smokers become able to accept cravings without acting on them. It is 
possible that this mechanism was occurring in a study by Elwafi et al. (2013), mentioned 
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above. Their finding of a decoupling between craving and smoking could be explained by an 
increased inhibitory control developed through mindfulness practise. Also in support of this 
mechanism, Berkman, Falk, & Lieberman (2011) have shown that increased inhibitory 
control is related to an increased ability to inhibit automatic responding to cravings. Baseline 
fMRI activity during a Go/NoGo task was measured in participants attempting to quit 
smoking through professionally-led cessation programmes such as Freedom From Smoking. 
Experience-sampling for 3 weeks, 8 times daily was employed to measure “everyday self-
control”. Increased activation in the basal ganglia, pre-supplementary motor area (pre-SMA), 
and IFG (inferior frontal gyrus) at baseline was correlated with an attenuated association 
between craving and smoking (Berkman et al., 2011). Because this decoupling is similar to 
that seen in Elwafi et al. (2013), there is rationale to hypothesise that mindfulness attenuates 
the association of craving and smoking through improving neural markers of early inhibitory 
control. Tang et al. (2013) did not find this decoupling, which may be because they used 
inappropriate measures of craving. “How much are you craving a cigarette right now?” used 
by Berkman et al. (2011) could evoke a different answer to a rating of the “severity of 
craving” (used in Tang et al. 2013). Tang et al. (2013) appear to measure attitude towards 
craving rather than craving itself. Using appropriate measures of craving could show that 
mindfulness decouples craving and smoking through increasing neural markers of early 
inhibitory control such as the NoGo N2 amplitude.  
Another, although less researched mechanism through which mindfulness might 
reduce smoking is by altering processing bias to smoking-related and affective cues. One 
study showed that an 8-week mindfulness-based programme reduced attentional bias to pain 
stimuli (e.g., picture of a broken leg) in chronic pain sufferers (Garland et al., 2013). Other 
studies have measured the relationship between attentional bias and dispositional mindfulness 
using the Five-Factor Mindfulness Questionnaire (FFMQ). This is a 39-item scale that 
measures 5 constructs related to mindfulness including non-reactivity to inner experience, 
non-judging of inner experience, observation of sensations and perceptions, acting with 
awareness, and describing and discriminating emotional experiences. Garland, Boettiger, 
Gaylord, Chanon, & Howard (2012) measured the association between higher trait-
mindfulness and behavioural attentional bias to alcohol stimuli in recovering alcoholics. 
Although they were unable to show behavioural alcohol-attentional bias, higher trait-
mindfulness showed an association with greater recovery of heart-rate variability to alcohol 
stimuli. While this finding suggests mindfulness can promote faster physiological recovery to 
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drug stimuli, it does not show how mindfulness affects initial reactivity or attentional bias to 
drug stimuli.  
Another study using EEG showed associations between high trait-mindfulness and 
lower LPP amplitudes to intrinsically pleasant and unpleasant images in healthy subjects 
(Brown, Goodman, & Inzlicht, 2013). In contrast to Brown et al. (2013), a more recent study 
by Garland, Froeliger, & Howard (2015) suggests that mindfulness increases LPP amplitude 
to intrinsically pleasant stimuli. This was shown in a group of participants with chronic pain 
and opiate misuse who underwent two ERP sessions, separated by an 8-week mindfulness-
based intervention. At the end of the intervention, participants who received the mindfulness-
based intervention had increased LPP amplitude (400–1000 ms) compared to baseline in 
response to rewarding stimuli while no increases of LPP were observed in response to neutral 
stimuli. Furthermore, these increases were not seen in the control group that received 
therapeutic and group support. It is suggested that mindfulness interventions may remediate 
reward-processing deficits in addiction, such that individuals become more attentive to 
natural rewards (e.g., food).  
Therefore, mindfulness-based interventions may also remediate reward-processing 
deficits in smokers through increasing P3 and LPP amplitudes to pleasant stimuli and perhaps 
reducing those in response to unpleasant stimuli, as suggested by Garland et al. (2013). 
Although results from Brown et al. (2013) would suggest a different responding to pleasant 
stimuli, this could be because his study compared responding to high arousal images 
(mutilation and erotica) as opposed to lower arousal images (garbage and flowers) used in 
Garland et al. (2015). The lower LPP amplitudes for non-mindful participants seen by 
Garland et al. (2015) may reflect lower levels of “awareness” while higher LPP amplitudes 
for non-mindful participants in Brown et al. (2013) could reflect lower levels of “non-
reactivity.”  
While mindfulness might lead to increased P3 and LPP responding to pleasant images, 
responding to smoking-related stimuli is less clear. Although Elwafi et al. (2013) found a 
decoupling of craving and smoking during the first 4-weeks of mindfulness treatment, a 
positive correlation re-emerged at 6-weeks, which then increased at 3 and 4 months. This 
suggests that while inhibitory control is important in the early stages of mindfulness-based 
smoking cessation, craving may be more important for long-term abstinence. It seems that 
being more aware of cravings, encouraged in mindfulness, would at least initially make those 
cravings stronger. In the same way this may lead to initial increases in processing bias to 
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smoking cues. This may then drop with repeated practice indicating increased tolerance and 
decreased reactivity to smoking cues.  
Overall, there is evidence of mindfulness interventions improving smoking-cessation 
outcomes over the current mainstay treatment of skills-training. There is also a promising 
case for mindfulness to improve inhibitory control and restore abnormal processing to drug-
related and affective stimuli. These mechanisms may reflect the ability of mindfulness to 
break down incentive salience attributions, which could lead to better smoking-cessation 
outcomes and less likelihood of relapse. 
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2 Aims and hypotheses 
Mindfulness offers an appealing behavioural alternative to the skills-training 
techniques taught in counselling. Previous research leads us to suggest that mindfulness can 
reduce smoking through increasing inhibitory control and decreasing smoking-related 
processing bias. Mindfulness may also increase processing of affective (pleasant and 
unpleasant) and neutral stimuli. Mindfulness has shown promising efficacy for smoking-
cessation when delivered in the form of group therapy, and this intervention has recently been 
formulated into a smartphone-based app called Craving to Quit. The current study aimed to 
test the effectiveness of Craving to Quit. If effective, the app would be a cost-effective way to 
distribute support for smoking-cessation on a national level. In addition we aimed to explore 
the mechanisms behind mindfulness, which could support the theoretical effectiveness of 
mindfulness and/or guide development of future addiction-related treatments.  
2.1 The original proposal 
Originally the study aimed to compare the effects of a mindfulness-based smoking-
cessation app, Craving to Quit, with one based on skills-training: QuitPal. We aimed to 
compare them by measuring behavioural and EEG variables at 2 sessions, 4 weeks apart. We 
had originally aimed to match the 2 interventions on all factors other than mindfulness (see 
Appendix A for comparison of key processes involved in apps). This was so that we could 
make stronger inferences about the effect of mindfulness on smoking-cessation and the 
mechanisms involved. Unfortunately, despite many efforts, recruitment was poor. We chose 
to drop the QuitPal group to retain more numbers in the Craving to Quit group, which 
consequently limited the scope of our study. In addition we loosened the inclusion criteria, in 
order to include less dependent and older smokers. 
We also had problems with compliance in the smoker group meaning that some key 
measures of the study had to be dropped. These included experience-sampling, weekly, and 
monthly follow-up questionnaires.  
The hypotheses described below and following methods section is a reflection of what 
the final study was able to achieve. 
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2.2 The current study 
We aimed to replicate several findings including: 
1. A smoking-related image processing bias in smokers relative to non-
smokers, indicated by higher P3 and LPP amplitudes for smoking images in 
smokers at baseline (Littel & Franken, 2007; McDonough & Warren, 2001; 
Minnix et al., 2013).  
2. Lower inhibitory control in smokers relative to non-smokers, indicated by 
lower Go/NoGo accuracy (Luijten et al., 2011; Yin et al., 2015), NoGo N2 
(Buzzell et al., 2014; Luijten et al., 2011; Yin et al., 2015) and NoGo P3 
amplitudes at baseline. 
3. No difference in smokers and non-smokers for low-arousal pleasant, 
unpleasant, and neutral stimuli (Minnix et al., 2013).  
4. The ability of a mindfulness-based intervention to reduce smoking status 
(number of cigarettes smoked/day) (Bowen & Marlatt, 2009; Brewer et al., 
2011). 
Aims 1 and 2 are important because they contribute to the interpretations for 
Hypotheses 1, 3 and 4, below. Likewise, Aim 3 would help with the interpretation of results 
from Hypothesis 4, i.e., does the intervention alter variables that were normal or abnormal to 
start with. Finally, Aim 4 is important because several of our hypotheses are related to 
discovering the mechanisms of this process.   
We had 7 specific, and novel hypotheses relating to these replication aims: 
2.2.1 Hypothesis 1: Behavioural markers of inhibitory control 
Question and significance 
There are currently no studies that have investigated effects of a mindfulness-based 
intervention on behaviour associated with an inhibitory control task in smokers. We aim to 
test this because the results will increase our understanding of the mechanisms involved in 
mindfulness-based interventions for smoking cessation. This will be tested by measuring 
accuracy in the Go/NoGo task before and after use of Craving to Quit in smokers. 
Hypothesis and rationale 
We hypothesise that a mindfulness-based intervention would increase behavioural 
markers of improved inhibitory control in smokers. This is because previous studies have 
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shown that a mindfulness-based intervention can increase MRI neural markers of inhibitory 
control (see section 1.6).  
2.2.2 Hypothesis 2: ERP markers of inhibitory control 
Question and significance 
There are currently no studies that have investigated effects of a mindfulness-based 
intervention on ERPs associated with an inhibitory control task in smokers. We aim to test 
this because the results will increase our understanding of the mechanisms involved in 
mindfulness-based interventions for smoking-cessation. This will be tested by measuring 
ERPs and behaviour elicited by the Go/NoGo task before and after use of Craving to Quit in 
smokers.  
Hypothesis and rationale 
We hypothesise that a mindfulness-based intervention would increase ERP markers of 
improved inhibitory control (NoGo N2 and P3) in smokers. This is because previous studies 
have shown that mindfulness can increase MRI neural markers of inhibitory control (see 
section 1.6). 
2.2.3 Hypothesis 3: ERP markers of increased image processing of pleasant, 
unpleasant, and neutral stimuli. 
Question and significance 
There are currently no studies that have investigated effects of a mindfulness-based 
intervention on ERPs associated with neutral, pleasant, and unpleasant image processing in 
smokers. We aim to test this because the results will increase our understanding of the 
mechanisms involved in mindfulness-based interventions for smoking cessation. This will be 
tested by measuring P3 and LPP elicited by neutral, pleasant and unpleasant images before 
and after use of Craving to Quit in smokers. If Craving to Quit increases image processing, 
the results of Aim 3 could indicate whether increases were from a normal or abnormal 
baseline. 
Hypothesis and rationale 
We hypothesise that a mindfulness-based intervention would increase ERP markers of 
image processing in response to neutral, pleasant and unpleasant images at follow-up, 
indicating a generalised increase in image processing in smokers. This is because the 
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acceptance fostered in mindfulness may increase processing of stimuli. A mindfulness 
intervention has also been shown to increase processing of intrinsically pleasant stimuli in 
opiate addiction (Garland et al., 2015). 
2.2.4 Hypothesis 4: ERP markers of processing bias to smoking-related images 
Question and significance 
No current study has investigated the effects of a mindfulness-based intervention on 
ERPs associated with smoking-related image processing in smokers. We aim to test this 
because the results will increase our understanding of the mechanisms involved in 
mindfulness-based interventions for smoking cessation. This will be tested by measuring P3 
and LPP elicited by the smoking-related images before and after use of Craving to Quit in 
smokers. 
Hypothesis and rationale 
We hypothesise that a mindfulness-based intervention would decrease ERPs 
associated with smoking-related image processing bias in smokers. This is because higher 
mindfulness has been associated with less drug-related processing bias in alcoholism (Garland 
et al, 2012). In addition, we suggest that mindfulness can remediate reward-processing 
deficits (see section 1.6), which may involve normalising image processing bias of drug-
related stimuli. 
2.2.5 Hypothesis 5: Craving to Quit will increase mindfulness at follow-up. 
Question and significance 
There are currently no studies that have investigated effects of a mindfulness-based 
intervention on mindfulness in smokers. We aim to test this because the results will increase 
our understanding of the mechanisms involved in mindfulness-based interventions for 
smoking cessation. This will be tested by measuring the five facets of the Five-Factor 
Mindfulness Questionnaire (FFMQ) (Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006) 
before and after use of Craving to Quit in smokers. 
Hypothesis and rationale 
We hypothesise that a mindfulness-based intervention would increase mindfulness at 
follow-up. This is because mindfulness-based interventions teach individuals to be more 
mindful. 
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2.2.6 Hypothesis 6: Craving to Quit will reduce smoking 
Question and significance 
There is nothing in the literature to indicate whether or not a mindfulness-based 
smoking-cessation app can reduce smoking status. We aimed to test this because if a 
smartphone app shows effectiveness for smoking-cessation it will provide an easily accessible 
and cost-effective way to target smoking-cessation at a large scale. This will be tested by 
comparing smoking status of smoker participants before and after use of Craving to Quit. 
Hypothesis and rationale 
We hypothesise that the Craving to Quit app would reduce smoking status in smokers 
who were motivated to quit. This is because Brewer et al. (2011) showed that a mindfulness-
based smoking cessation intervention was effective in reducing smoking, when delivered in 
the form of group therapy. 
2.2.7 Hypothesis 7: Decoupling of craving and smoking 
Question and significance 
Although Elwafi et al (2013) have shown that a mindfulness-based intervention 
delivered via group therapy can decouple the link between smoking and craving, there is 
nothing in the literature to indicate whether or not the same pattern can occur when the 
intervention is adapted to a smartphone app. We aim to test this because it will add support 
for the proposed decoupling mechanism of mindfulness and support the application of a 
mindfulness-based intervention to smartphone app. Measuring correlations between smoking 
status and craving in smoker participants who had used Craving to Quit will test this. 
Hypothesis and rationale 
We hypothesise that there would be no correlation between craving and smoking 
status at 1–2 month follow-up of smokers. This is because Elwafi et al. (2013) showed that a 
mindfulness-based smoking-cessation intervention, delivered in a group, could decouple the 
link between craving and smoking. 
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3 Methods 
3.1 Participants 
3.1.1 Power analysis 
We estimated the number of participants needed to observe a small effect size (25%) 
with 90% power at baseline, using the standard deviation and mean taken from findings of P3 
elicited by non-smokers at PZ (Littel & Franken, 2007). We estimated this by using the 
formula, n = 1+2C(s/d)2 (US National Research Council, 2003), where C was 10.51, 
representing 90% power for a significance level of p = 0.05, s is the estimated standard 
deviation of the variable that we intended to measure (P3), and d was the 25% difference from 
the estimated mean that we wished to detect. Using this formula it was estimated that we 
would need 8 participants per group (n = 1 + (2 x 10.51) (6.37/11.1)2 ) to show differences 
between smokers and non-smokers in response to smoking images.  
When we began the study, there was no previous literature available to indicate how 
many participants would be needed to show a change in ERPs or Go/NoGo accuracy within 
groups. Previous studies showing change in smoking status did not provide means or standard 
deviations to use in an estimated power analysis. These studies examined abstinence rather 
than number of cigarettes smoked per day. Because of this, we decided to aim for 16 
participants per group to show differences at follow-up. This was twice as many as indicated 
by the power analysis for detecting differences at baseline. 
3.1.2 Participant screening  
The study aimed to recruit 16 smokers and 16 non-smokers between ages 18 and 65 
years to participate in a study assessing the effectiveness of smartphone-based behavioural 
interventions for smoking. To account for potential drop-outs, we initially recruited 18 non-
smokers (mean age = 25.17, SD = 7.15, 44.4% male, 55.6% female) and 37 smokers (mean 
age = 32.46, SD = 12.01, 48.6% male, 51.4% female). The majority of participants were to be 
recruited from the Canterbury of University campus using advertisements distributed 
physically and via departmental emails. Because this yielded a low number of people 
engaging in the survey, we also attempted to recruit from Lincoln University, Christchurch 
Polytechnic Institute of Technology, Otago Medical School, Christchurch Public and Princess 
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Margaret Hospitals, Hagley Radiology, various workplaces, local GPs, SmokeFree 
Canterbury, occupational health nurses at various large construction companies, and various 
Facebook groups including “Christchurch Buy, Sell and Trade.” See Appendix B for 
advertisement. The majority of recruited non-smoker controls were from the University of 
Canterbury, while the majority of those in the smoker group were recruited from “Buy, Sell 
and Trade” groups on Facebook. 
Participants were excluded if they have had a serious or unstable medical condition 
within the last 6 months, were currently taking psychoactive medication (e.g., neuroleptics, 
anxiolytics, and antidepressants) or answered “Yes” to either themselves, family, or close 
friends considering them to being “a heavy user of any recreational drug other than nicotine 
(e.g., alcohol, marijuana, ecstasy).” Additional exclusion criteria for smokers included current 
involvement in any smoking-cessation activities (Versace et al., 2011), including nicotine-
replacement therapy, and a score of less than 3 out of 7 on the Motivation To Stop Scale 
(MTSS). 
Inclusion criteria for smokers was smoking ten or more cigarettes a day, a Fagerstrom 
Test for Nicotine Dependence (FTND) value of at least 3 (low) nicotine dependence, having 
less than 3-months abstinence within the last year, wishing to cease smoking, and having an 
iPhone Model 4 or later or a smartphone with Android Model 2.3.3 or later. Smoker 
participants who smoked less than 10 cigarettes a day were included if they had a FTND 
score of 4 or more. Inclusion criteria for non-smokers were having smoked less than 10 
cigarettes during their lifetime (Luijten et al., 2011) or having smoked none within the past 20 
years. The latter criterion was added because we observed from initial screening results that 
participants over 30 were unlikely to have smoked less than 10 cigarettes within their lifetime, 
even if they considered themselves “non-smokers.” 
The screening was done via a confidential online survey that was made using an 
online research software called “Qualtrics” (www.qualtrics.com). Contact details were asked 
at the end of the survey for those who were eligible. Eligible participants were then sent an 
information sheet and encouraged to book their first test session. Recruitment of participants 
was approved by the University of Canterbury Human Ethics Committee (see Appendix C). 
Over 600 people started the survey, but many people were either did not finish, were not 
eligible, not interested, or interested but did not turn up to their first booked session. The main 
reason for exclusion of potential smoker participants was that they had lower scores of the 
FTND, or reported smoking a lower number of cigarettes/day than the minimum 
requirements. The main reason for exclusion of potential non-smoker participants was that 
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they had smoked more than 10 cigarettes within their lifetime or had smoked within the last 
20 years. 
3.2 Tasks 
3.2.1 Go/NoGo task 
To measure inhibitory control, a Go/NoGo task was developed on E-Prime 2.0 
software using the letters ‘M’ and ‘W’ as both Go and NoGo stimuli. The task involved 4 
blocks of 128 trials with 75% Go and 25% NoGo trials. Two versions of the task were 
developed. One version used the letter ‘M’ as the Go stimulus for the first 2 blocks, the other 
used ‘W.’ At half-way (block 3) the Go and NoGo stimuli were reversed (i.e., the Go stimulus 
became the NoGo stimulus and vice versa).  
Each block began with a white fixation cross, displayed for 250 ms. This was 
followed by the letter stimulus (either ‘M’ or ‘W’) presented for 500 ms or terminated on key 
press. Trials finished with a 500-ms black screen. This was the same timing procedure used as 
by Dong, Lu, Zhou, & Zhao (2010) and was chosen over longer inter-trial intervals in order to 
obtain more trials to average for our ERPs. 
Participants were instructed to press the spacebar key each time they saw the Go 
stimulus, and NOT to press it when they saw a NoGo stimulus. Participants were told to 
respond using either the middle or index finger of their dominant hand. They were instructed 
both written and verbally to respond as quickly and as accurately as possible.  
Participants were given a practice block of 30 trials. During the practice block, 
feedback was given for correct hits and rejections as well as misses and false alarms. The 
feedback was presented as white italicised text on the 500 ms black screen that followed each 
stimulus.  
Between each of the 4 experimental blocks was a 1-min break, in which “Break. 
Please relax in your chair” was presented in white text on a black screen for 30 s followed by 
a 30-s countdown, also in text. Halfway through the experiment, participants were presented 
with an instruction screen explaining the change in Go and NoGo stimuli. The screen was 
terminated on key press and was followed by a break screen.   
All stimuli and text were presented in 18 pt. white Courier New font on a black 
screen. Participants were seated approximately 0.5–1.0 m away from the screen. The task 
took around 15–20 min. 
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3.2.2 Image slideshow 
To measure attentional and emotional image processing bias an “image slideshow” 
was developed similar to that of Versace et al. (2011), using E-Prime 2.0 software. The image 
slideshow involved 4 categories (neutral, unpleasant, smoking and pleasant) of 36 different 
images. Each image was presented twice giving a total of 288 images. Images were selected 
from the International Affective Picture Set (IAPS) (Lang, Bradley, & Cuthbert, 2005) and 
the International Smoking Images Series (ISIS) (Gilbert & Rabinovich, 1999), and were 
sorted into categories by using separate normed ratings for valence and arousal from the IAPS 
and ISIS groups. These average ratings are as follows (valence and arousal, respectively): 
neutral: 4.98, 2.86; pleasant: 7.39, 5.26; unpleasant: 2.68; 5.31; smoking: 5.36, 3.78. Note that 
these norms were created using different groups of participants. The provided norms for the 
smoking images are from smoker-participants only. 
Pleasant, unpleasant, and neutral categories all had a 1:1 ratio of images involving 
people and images not involving people (e.g., objects, scenery). The same could not be done 
for the smoking set because the majority of images with available normed ratings involved 
people. 
The slideshow was separated into 8 blocks of 36 trials. Each trial involved a 2500 ms 
display of a white fixation cross in the centre of a black background, followed by a 2000 ms 
image display. For each block a pseudo-random trial list was created. The list was of 36 trials 
involving 9 trials for each of the 4 image categories. No more than two trials of the same 
category were presented consecutively. During the slideshow the trial lists (blocks) were 
shown in random order. For each trial in the list a random image of that category was shown. 
No image was presented more than twice during the whole slideshow.  
 Five trials out of each trial list were “noise” trials. These trials had a longer fixation-
cross display of 6050 ms. During these trials a 50-ms burst of white noise would play through 
earphones. The noise would occur at 1 of 4 random times within the first 550 ms of the 
fixation-cross display. The noise trials would occur pseudo-randomly at every 4th, 5th, or 8th 
image. The purpose of the noise was to keep participants focused. The longer fixation-cross 
display was to give enough time for participants’ EEG to return to baseline in case the noise 
introduced EEG artefact. 
Participants were instructed both written and verbally to relax and watch the image 
slideshow while trying to remain as still as possible.  
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Between each block, participants were given 30-s breaks involving a 10-s countdown 
displayed in white font on a black computer screen. All text was presented in 18 pt. white 
Courier New font. 
At the beginning of the experiment, participants listened to five examples of the white 
noise. These occurred during pseudo-random intervals of 25–44 s. These intervals mirrored 
the intervals that occurred in the blocks.  
The total task took about 30 min. 
3.3 Interventions 
Smoking participants would use their personal smartphones for the following 
intervention. 
3.3.1 Craving to Quit (C2Q) 
Within the Craving to Quit application (Figure 3.1) is a 22-day programme for 
quitting smoking. The programme involves a gradual cut-down of smoking over 3-weeks 
until the “quit day” at Day-21. Users are sent app notifications each day for suggested number 
of cigarettes to smoke. This is based on the average number of cigarettes smoked/day that 
users enter into the app at the start of the programme. This average is then tapered by 1/21 for 
each day of the programme. For each day until the designated quit day, the app has a list of 
“Today’s activities” and “Today’s goal” including short videos and audio recordings that 
introduce new mindfulness techniques. Figure 3.2 shows an example this in Day 3 of the 
programme. The videos and recordings firstly explain the rationale behind each exercise, and 
then guide the participant through practising it. These videos often explain exercises using 
metaphors or analogies. For example, the ‘RAIN’ (Recognise, Accept, Investigate, Note) 
exercise teaches participants to ride out cravings through likening their cravings to waves and 
likening mindfulness to a surfboard that is used to ride the waves. The RAIN exercise is in the 
form of an audio recording, and is encouraged to be used every time the user has a craving to 
smoke. This replaces distraction and avoidance techniques, which are encouraged in skills-
training. The app has an “Exercises” feature where users can access a list of exercises 
including meditation practices and motivational videos. Over the course of the programme 
each exercise becomes assessable once it has been introduced in “Today’s activities.” Each 
meditation exercise takes between 6 and 10 min to complete. The app also has a “Night 
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Reflection” feature (Figure 3.2) where users can reflect on the day’s goals and complete a 
meditation practice (e.g. Body Scan and Loving Kindness). 
At the beginning of the app, users enter a quitting pact, which can be visited at any 
time throughout the programme. This includes a record of when the user began their quitting 
pact, their planned quit date, the amount of money they will save each month (based on 
current smoking rate and average price of cigarettes), and 3 personalised goals for quitting. 
On Day-6, users record their triggers for smoking into their quitting pact, and on Day-20 they 
decide on a “mantra,” which is also entered into the quitting pact. A mantra is a saying that 
users can repeat to themselves whenever they have a craving to smoke, e.g., the mantra “not 
even one,” reminds the user that they should not smoke even one cigarette. Day-22 shows a 
video explaining how users can stay “on track” after quitting on Day-21. In addition to the 
programme, the app sends several reminders throughout the day to “Check-In.” This is a 
feature that involves asking users their current craving and number of cigarettes they have 
smoked since the last reminder. Their craving can be measured using the “Want-O-Meter” 
feature, and cigarettes smoked can be measured used the “Tracker.” 
Within the app, users can access the “Community” feature (Figure 3.2), which takes 
them to an online Craving to Quit forum. Here, users can create a personal profile and 
connect with others also using the C2Q app. Users can interact with each other via private or 
public messages and can also ask questions to psychiatrist Dr Judson Brewer through the 
“Ask the Doc” feature. Within the Craving to Quit forum, users can post public journal 
entries for which other users and Dr Judson Brewer can comment on and provide feedback.  
Other features of the app include: “Reminder Settings,” where users can change the 
frequency of “Check-In” notifications, “Activity Feed,” in which users can look at their recent 
activity on the app (e.g., videos watched), and “My Morning Stats” which shows users their 





























Figure 3.1. Craving to Quit title screen (left) and main screen (right) showing Days 1 and 2 of 
the 22-day programme. 
Figure 3.2. Activities and goals for Day 3 of the programme showing several app features: 
Want-O-Meter, Tracker, Exercises (left), Activity Feed, My Morning Stats, Night Reflection, 
Reminder Settings, Quitting Pact, Check-In, and Community (right). 
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3.3.2 No Intervention  
Non-smoker participants received no intervention and were instructed to “continue life 
as normal” until their second session (see Appendix F for control handout).  
3.4 Procedure 
Participants were first screened using the online Qualtrics survey, and sent an 
information sheet (Appendix D) if they were eligible for the study. Individual morning 
appointment times (starting between 7.30 a.m. and 10.30 a.m.) for Session 1 were booked for 
people who had passed the screening survey and agreed to participate in the study. Before the 
Session 1, participants were assigned to an intervention group. This was Craving to Quit for 
smokers and No Intervention for non-smokers. All participants were sent instructions on how 
to prepare for their visit (Appendix E). Smokers were asked to abstain from smoking for 8 hr 
before the experiment. This is to reduce acute effects of nicotine on ERP amplitudes and to 
make sure all participants were equivalent for levels of nicotine. 
Participants were talked through the structure of the session on arrival and shown the 
EEG cap. This included explanation of all the preparation in setting up the cap, gel, and 
external electrodes. After participants signed the consent form the EEG cap was set up. 
Following set up of the cap, the experimenter explained the first task, the Go/NoGo 
task, and was present during the practice trials. After the Go/NoGo experimental trials, 
participants had a short break while the experimenter loaded the image slideshow task. During 
the experimental trials of both tasks, the experimenter was in an adjacent room.  After this 
task the participants moved on to the image slideshow, then completed the FFMQ 
questionnaire online and were pencilled in for their second session. 
Smoker participants also completed the QSU-brief online before completing the 
FFMQ. Both questionnaires were converted to an online form using Qualtrics. After the 
online questionnaires the experimenter helped participants set up a personal username and 
password for the C2Q app. Participants were given detailed instructions of how to use the 
C2Q app (see Appendix F for C2Q and Control handouts).  To motivate participants to 
continue use of the C2Q app, weekly phone calls and texts were sent to check in with how 
participants were going. We were able to track participant use of the app and those who 
stopped using it were sent a “Getting back on track” email (see Appendix G). Tracking 
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allowed us to see when follow-up sessions needed to be rescheduled. We aimed to receive 
participants for Session 2 once they had completed at least 70% of the programme. 
  All participants completed the same tasks at Session 2 as in Session 1 and were 
given a $20.00 petrol, supermarket, or Westfield voucher for their time, and a debriefing 
sheet, which explained the purpose of the project (see Appendix H). Session 2 was between 3 
weeks and 2 months from Session 1. As with Session 1, smokers were asked to abstain from 
nicotine for 8 hours before the experiment. The procedure is summarized in Table 3.1. 
Table 3.1. Procedure summary showing tested variables and estimated time involved for each 
main phase of the experiment (bold). 
 
In the handouts designed for the original study (see section 2.1) participants were also 
asked to record their smoking status and craving each day from Session 1 up until Session 2 




Session 1 Image P3, LPP 





Intervention No intervention 
C2Q 
1–2 month 
Session 2 Image P3, LPP 
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(experience-sampling) via text messaging and to complete 4 x weekly follow-up 
questionnaires. We planned to use experience sampling to investigate correlations between 
craving and smoking throughout use of the app. This was changed because of low compliance 
and instead participants were given a sheet of paper to record smoking status and craving and 
were asked to complete only a 1 x monthly follow-up questionnaire. Even after these changes, 
the measures still yielded a low response, which led us to drop both the experience-sampling 
and follow-up questionnaires completely. As mentioned in section 2.1, the key comparison 
group receiving QuitPal was also dropped from the design. See Appendix I for the methods 
summary and handout for QuitPal, and the daily texts that were designed to go with this 
intervention. 
3.5 Measures 
3.5.1 Fagerstrom Test for Nicotine Dependence (FTND)  
The FTND is a 6-item self-reported questionnaire (Heatherton, Kozlowski, Frecker, & 
Fagerstrom, 1991). The points for each answer are added to give a total score between 0–10 
of nicotine dependence. The categories of nicotine dependence ranged from very low (0–2), 
low (3–4), medium (5), high (6–7), and very high (8–10) (Fagerstrom et al., 1990).  
3.5.2 Behaviour on the Go/NoGo Task 
The reaction time for correct Go trials and commission errors were calculated, as well 
as the percentage of correct hits and rejections for Go and NoGo trials, respectively (Smith et 
al., 2013). 
3.5.3 Craving: QSU-brief 
The Brief Questionnaire of Smoking Urges (QSU-Brief) (Cox, Tiffany, & Christen, 
2001; Tiffany & Drobes, 1991) was used to measure self-reported nicotine craving for at 
Sessions 1 and 2. The QSU-brief is a 10-item questionnaire measured on a scale of 1 (strongly 
disagree) to 7 (strongly agree). Total craving was recorded as a score between 10 and 70. 
3.5.4 Smoking Status 
Baseline smoking status (average number of cigarettes smoked/day) was measured 
from each participant’s registration on Craving to Quit. Follow-up smoking status was 
	   40	  
measured by a question tagged onto the end of the QSU-brief questionnaire in Session 2: “On 
average, how many cigarettes per day have you smoked during the last week.” 
3.5.5  Motivation to Stop Scale (MTSS) 
The MTSS was used to measure each smoker-participant’s motivation levels for 
quitting smoking. This is a one-item scale, which asks “Which of the following describes 
you?” The possible responses to choose from include: (1) “I don’t want to stop smoking”; (2) 
“I think I should stop smoking but don’t really want to”; (3) “I want to stop smoking but 
haven’t thought about when”; (4) “I REALLY want to stop smoking but I don’t know when I 
will”; (5) “I want to stop smoking and hope to soon”; (6) “I REALLY want to stop smoking 
and intend to in the next 3 months”; and (7) “I REALLY want to stop smoking and intend to 
in the next month.” The following interpretations are listed for each response: 1- absence of 
any belief, desire, or intention; 2- belief only; 3- moderate desire but no intention; 4- strong 
desire but no intention; 5- moderate desire and intention; 6- strong desire and medium-term 
intention; and 7- strong desire and short-term intention (Kotz, Brown, & West, 2013).  
3.5.6 Mindfulness 
Mindfulness was measured using the Five-Factor Mindfulness Questionnaire (FFMQ) 
(Baer et al., 2006) which assesses several factors including observing, describing, acting with 
awareness, non-judging of inner experience, and non-reactivity to inner experience.  
3.5.7 EEG Recording and Data Reduction 
The EEG was recorded using a Neuroscan SynAmps2TM Model 8050 EEG amplifier 
(Compumedics Neuroscan, USA). Recordings were made at 64 scalp sites with Ag/AgCl 
electrodes mounted in an elastic cap, (Neuroscan Quik-Cap, Compumedics USA). In addition, 
4 electrodes were placed outside of the cap, one above and one below the eye to record 
vertical eye movement, and 2 placed on the left and right mastoids. Online continuous EEG 
was initially recorded using a bandpass of 1.0–40.0 Hz but later changed to a bandpass of 
DC–200.0 Hz.  During recording, EEG was referenced to an electrode between CZ and CPZ 
using Neuroscan Acquire 4.4 (Neuroscan Compumedics, USA) at a sampling rate of 1000 Hz. 
Offline data was filtered using Neuroscan EDIT 4.4 (Neuroscan Compumedics, USA) 
with a FIR analogue filter and bandpass of 1.0–30.0Hz using a 48 dB/octave cut-off. Other 
ERP studies generally use a lower high-pass filter of 0.1 Hz but because approximately a third 
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of participants were recorded online with a high-pass of 1.0 Hz, we filtered all at 1.0 Hz to 
ensure ERPs were comparable.  
All channels were visually inspected before re-referencing. Channels that appeared to 
have come off during the recording or had impedances over 100 kΩ were interpolated using 
2–4 nearby channels. This was done through the Linear Montage Editor, as suggested by 
Neuroscan Compumedics. Three different references were tested, including the original 
(between CZ, CPZ), the average of left and right mastoids, and the average reference of all 
electrodes. The average reference gave the cleanest EEG recordings and largest ERP peaks, 
so was chosen as the final reference. After interpolation and re-referencing, ocular artefact 
was corrected for. Continuous EEG was segmented into 1000 ms epochs for the Go/NoGo 
recordings, and 2000 ms epochs for the image slideshow recordings. Epochs were baseline-
corrected for 200 ms preceding stimulus onset for both task recordings.  Epochs with an EEG 
amplitude above 75 or below -75 μV were excluded from averaging. The final epochs for 
each participant were then averaged to give an ERP for each scalp site. In the Go/NoGo task, 
N2 was defined as the most negative amplitude between 220 and 310 ms at FZ, F1, F2, FCZ, 
and CZ, while P3 was defined as the most positive value between 300 and 500ms at FCZ, CZ, 
C1, C2, and CPZ. In the image slideshow, P3 was defined as the maximum voltage between 
300 and 500ms at FZ, F1, F2, FCZ, CZ, and CPZ. The early LPP (E.LPP) was defined as 
average amplitude between 600–1000 ms at FZ, F1, F2, FCZ, CZ, and CPZ. Late LPP 
(L.LPP) was defined as average amplitude between 1000–1500 ms at FZ, F1, F2, FCZ, CZ, 
and CPZ, and as average amplitude between 1500–2000 ms at PZ, P1, and P2. The reasons 
choosing these time windows are discussed in section 5.1. 
3.6 Statistical analyses 
All EEG and Go/NoGo behavioural data were tested for normality by examining 
scores of kurtosis and skewness. The majority of data had scores of kurtosis and skewness 
that were within the recommended range for normality for each sample size and had non-
significant heterogeneity, determined by the Levene’s test. We also tested sphericity of data 
using Mauchley’s test. For most analyses sphericity was not violated. Because of this we 
decided to compute Analyses of Variance (ANOVA) to investigate interactions for EEG data 
and Go/NoGo behavioural data at both baseline and follow-up. We used a multiple 
comparison approach for data analysis. Although the majority of means comparisons were 
planned and hypothesis-driven, in some instances comparisons were made after inspection of 
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the data. For this reason, and for all dependent variables, family error rate was controlled for 
with the Student Newman-Keuls correction method for multiple contrasts. The sampling error 
was that of the high-order effect from a precursor ANOVA and was used as denominator for 
the q statistic, correcting for unequal sample sizes, as appropriate (Howell, 2010; Ryan, 1959; 
Wilcox, 1987). Because the sampling error and degrees of freedom were obtained from 
precursor ANOVA, we report the partial eta-squared values (ηp2) for effect size. We analysed 
up to 9 electrodes for each EEG variable (image slideshow P3, E.LPP, L.LPP, N2, and 
Go/NoGo P3), and found that nearby electrodes often showed similar effects, but with 
different degrees of significance. Only results for electrodes in which statistical differences 
were found by way of multiple comparisons are reported. However, non-significant 
differences are interpreted accordingly in the Discussion section. ANOVA was used to 
analyse follow-up data for smoking status. Where sphericity was violated, values for the 
corrected Greenhouse–Geisser estimate are reported. For results of EEG and behavioural 
Go/NoGo data, values of partial eta-squared (ηp2) are reported from the ANOVA interaction, 
representing small (ηp2 = 0.01), medium (ηp2 = 0.06), and large (ηp2 = 0.14) effects (Cohen, 
1988). Cohen’s d effect size are reported for ANOVA result of smoking status, with d = 0.2, d 
= 0.5, and d = 0.8, indicating small, medium and large effects, respectively (Cohen, 1988).  
Mann-Whitney tests were used to test baseline FFMQ data, and Wilcoxon signed-rank 
tests for craving and FFMQ data at follow-up. Effect size, r, was used for Mann-Whitney and 
Wilcoxon signed-rank tests, as suggested by A. Field, (2013). 
Pearson correlations coefficients, r, were used to test decoupling of smoking status 
and craving at baseline and follow-up using one-tailed tests for correlation. For baseline and 
follow-up, r = 0.1, r = 0.3, and r = 0.5, were used to indicated small, medium, and large 
effects, respectively (A. Field, 2013). 
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4  Results 
4.1 Participants: Descriptive Statistics 
4.1.1 Baseline 
As indicated, we recruited a total of 55 participants (18 non-smokers and 37 smokers) 
between the ages of 18 and 63, who were tested at baseline. Three non-smoker participants 
had to be removed from the study because of noisy EEG data, in which the reference 
electrode came off. The EEG and behavioural data from the Go/NoGo task of an additional 
two non-smokers had to be removed, as participants did not understand the task and pressed 
spacebar for all stimuli. EEG data for the image slideshow is missing for two other non-
smoker participants because the experimenter did not press record. This meant that the final 
baseline non-smoker group for the image slideshow was different to that of the Go/NoGo task 
and both were different to the final FFMQ non-smoker group. Ages were significantly 
different between smoker and non-smoker groups for image slideshow [F(1,49) = 5.21, p = 
0.026], and FFMQ [F(1,50) = 4.39, p = 0.041], comparisons with non-smokers being younger on 
average. So that any differences in comparisons could not be attributed to age, two of the 
youngest non-smoker participants were removed from the study altogether.  
Due to the aforementioned incidences, all baseline analyses included 37 smokers 
while the number of non-smokers included at baseline differed for each analysis; FFMQ (n 
=13), Go/NoGo variables (n = 11) and image slideshow variables (n = 12). In all baseline 
analyses, the mean age of the smoker group was not significantly different to that of the non-
smoker group (Table 4.1). For all baseline analyses there was no difference in gender (Table 
4.2). On average, smokers tested at baseline had moderate nicotine dependence (M = 5.35, SD 
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Table 4.1: ANOVA results show that smokers and non-smokers do not differ in age at baseline. 




Out of the 37 smokers who completed Session 1, only 13 completed at least 70% of 
the app (16 days) within 2 months of starting it. Fifteen participants completed 3 or less days 
of the app, and 9 of these did not complete any days of the app. The remaining 9 participants 
used it for 6–14 days. 
Eleven of the smokers who completed at least 70% of the app returned for the second 
visit and all were included in follow-up analyses. All non-smokers returned for the second 
session, although one non-smoker could not be included in the follow-up analysis of the 
image slideshow because the experimenter forgot to record it. Table 4.3 shows that the 
smokers were not significantly different from non-smokers in age for FFMQ, image 
slideshow, and Go/NoGo analysis. Groups were also not significantly different in gender 




Baseline Analysis NS age M (SD) S age M (SD) F df p 
FFMQ 26.54 (7.83) 32.46 (12.01) 2.73 1,48 0.105 
Image slideshow 25.67 (7.49) 32.46 (12.01) 3.38 1,47 0.072 
Go/NoGo 27.00 (8.47) 32.46 (12.01) 1.97 1,46 0.167 
Baseline Analysis NS male:female S male:female F df p 
FFMQ 7:6 18:19 0.10 1,48 0.753 
Image slideshow 5:7 18:19 0.01 1,47 0.937 
Go/NoGo 5:6 18:19 0.11 1,46 0.536 
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Table 4.3: ANOVA results show that smokers and non-smokers did not differ in age at follow-
up. 
Follow-up Analysis NS age M (SD) S age M (SD) F df p 
FFMQ 26.54 (7.83) 29.09 (8.83) 0.56 1,22 0.461 
Image slideshow 23.83 (4.07) 29.09 (8.83) 3.24 1,20 0.087 
Go/NoGo 27.00 (8.47) 29.09 (8.83) 0.32 1,20 0.577 
Table 4.4: ANOVA results show that smokers and non-smokers did not differ in gender at 
follow-up. 
Follow-up Analysis NS male:female S male:female F df p 
FFMQ 7:6 7:4 0.22 1,22 0.646 
Image slideshow 5:6 7:4 0.17 1,20 0.937 
Go/NoGo 5:6 7:4 0.17 1,20 0.738 
Table 4.5: ANOVA results show that smoker and non-smokers did not differ for time between 
sessions. 
 Time between sessions (days)    
Follow-up Analysis NS M (SD) S M (SD) F df p 
FFMQ 34.38 (14.19) 40.64 (12.25) 1.31 1,22 0.265 
Image slideshow 32.81 (13.37) 40.64 (12.25) 2.04 1,20 0.168 
Go/NoGo 33.09 (12.69) 40.64 (12.25) 2.01 1,20 0.171 
 
4.1.3  Reasons for non-compliance 
Over 60% of the smokers used less than 70% of the C2Q programme (i.e., less than 16 
days) during the course of the study. Because of this, a multi-choice follow-up questionnaire 
for non-compliant participants, was created to examine which features put them off using the 
app. Non-compliant participants generally fell into one of 2 camps: Those who completed 3 
or less days (n = 15), or those completed 4–14 (n = 9) days of the app. Because of this, the 
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following questions were constructed: Q1: “Some participants completed less than 3 days of 
the Craving to Quit programme. If this was you, why did you not use if for longer?” and Q2: 
“Some other participants used the Craving to Quit programme for up to 2 weeks then stopped. 
If this was you, why did you stop?” Unfortunately we made a mistake, in that Q1 should have 
been “3 days or less” instead of “less than 3 days.” 
Text messaging feedback from some participants indicated that the app was helpful, 
but only during the first week of use. These same participants did not go on to complete the 
app. A third question was constructed to investigate why participants used some of the app 
then stopped: Q3: “Even those who completed the programme often missed 1 or several days. 
How did you feel when you missed a day of the programme?” 
Questions 1, 2, and 3 were e-mailed to 24 non-compliant participants in the form of a 
link to a single online Qualtrics questionnaire. Each question was multi-choice. Of those who 
were emailed links, 12 completed it. Most responded to both Q1 and Q2, i.e., did not choose 
one of the 2 camps described above. This is likely because some options for reasons of not 
using the app were under Q2 but not Q1, and vice versa. Because of this, results of Q1 and Q2 
were combined with Table 6 showing “reasons for why participants did not use the app for 
longer.” Table 4.6 shows the frequencies of responses to each multi-choice answer in Q1 and 
Q2. The most common reason for not using the app for longer was that the exercises were too 
long and “Other reasons.” There was the option for participants to enter text for “Other 
reasons.” Of those who did, responses included: “made me think about smoking more,” 
technical problems, the app was “hard to use and took a lot of time” and was not practical to 
use with people around. No one answered that they forgot to use the app, or that they were not 
seeing any benefits. 
Table 4.7 shows the frequencies of responses to each multi-choice answer in Q3. The 
most frequent response for how participants felt when they missed a day of the programme 
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Table 4.6: Reasons of why participants did not use the app for longer (Q1 and Q2 combined). 
























I forgot 0 
I didn’t have enough time 2 
I am not a mindfulness person so a mindfulness-based programme 
won’t work for me 
1 
I changed my mind about quitting 2 
The app had technical problems 2 
Stressful or important events came up 3 
I wasn’t seeing any benefits 0 
The app made me want to smoke 0 
The notifications were annoying 3 
I felt bad if I missed a couple of days and was told that I should be 
smoking less than I was 
3 
The exercises took too long 4 
It was not practical to use the rain exercise during the day 3 
I didn’t like the idea of mindfulness/ I got bored or irritated doing the 
mindfulness exercises 
2 
Other reasons 4 
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Table 4.7: How participants felt when they missed a day of the app. The most frequent answer 





4.2 EEG filtering observations: choosing appropriate ERP time windows 
4.2.1 Image slideshow task 
Upon visual inspection of ERPs elicited by the image slideshow task, the early LPP 
and late LPP appeared earlier and smaller at PZ compared to frontal and central sites, and the 
P3 peak was almost unrecognizable at PZ. This pattern had not been documented in previous 
literature and may be because of the higher high-pass filter used in the current study (1.0 Hz) 
compared to previous studies (0.1 Hz). 
To further investigate this frontal-parietal inconsistency, 0.1 Hz and 1.0 Hz high-pass 
filters were compared using data from the 13 participants who came to both sessions, and 
whose EEG had been recorded online with a DC–200 Hz band-pass. Visual inspection of 
ERPs showed reduced parietal positivity but increased frontal positivity during 1 s after 
picture onset, for the higher higher-pass filter (1.0 Hz). This pattern inversed during 1–2 s 
post-picture onset, showing increased parietal positivity and decreased frontal positivity with 
the 1.0 Hz high-pass filter (Figures 4.1 & 4.2).  
We were unable to reliably measure P3 amplitude at PZ. Hence, it was decided to only 
analyse P3 at frontal, frontal central, and centroparietal electrodes. At parietal electrodes, a 
Reasons Frequency 
Fine. I didn't mind picking up where I had left off if I had miss a day or 
several 
2 
Fine. I had already decided to stop using the app 3 
I felt guilty 3 
Disappointed in myself 3 
I felt like there was no point continuing because I had already "failed" 
the programme 
6 
I wanted to restart the programme and my quit attempt 3 
Other reasons 2 
	   50	  
large positive peak was observed at between 500—750 ms post stimulus-onset. This peak 
may have been a late P3 but exceeds the upper limit of time-windows used in other studies 
(600 ms), that tested a similar paradigm (Asmaro et al., 2014; Engelmann et al., 2011; Jang et 
al., 2007; Littel & Franken, 2007; Sarlo et al., 2013; Yücel & Lubman, 2007). There is only 1 
study to our knowledge that has measured P3 within latencies up to 800 ms post-stimulus 
onset (Wang et al., 2015), within a similar paradigm to the current study. Because of this, we 
were unsure of whether late P3 was a valid interpretation of the observed parietal peak, and 
we decided to not measure it. Originally we had planned to measure early and late LPP as 
average amplitude between 600–1000 ms, and 1000–2000 ms post-stimulus onset, 
respectively, and at frontal, frontocentral, centroparietal, and parietal electrodes. These 
definitions were the same as those used in Littel et al. (2011). In the current study, early and 
late LPPs appeared to occur at earlier latencies for parietal than frontal electrodes. Because of 
this our originally planned definitions were altered. Although it would have been preferable to 
have the same time-window definitions for parietal electrodes as for the other electrodes, 
separate time windows were used to ensure that adjacent negative components were not being 
measured that could reflect a different mental process. Because time-window definitions of 
early and late LPP vary in the literature, it was decided that this would be an acceptable 
compromise. At frontal, frontocentral, and centroparietal electrodes, the early LPP was 
defined as average amplitude between 600–1000 ms Littel & Franken (2011). The late LPP at 
PZ, P1, and P2 was defined as average amplitude over 1000–1500 ms after stimulus-onset, 
while at frontal, frontocentral, and centroparietal sites it was defined as over 1500–2000 ms. 
4.2.2 Go/NoGo task 
Upon visual inspection of ERPs elicited by the Go/NoGo task, differences between 
filtering (0.1 Hz vs. 1.0 Hz) had the most dramatic effects on later positive components 
occurring after 600 ms from stimulus onset (Figures 4.3 & 4.4). We did not intend to measure 
any later components so this was not a problem for the ERPs we intended to measure. It was 
observed that N2 could be reliably defined for our range of participants as peak negative 
amplitude between 220 and 310 ms after stimulus-onset, and P3, as peak positive amplitude 
between 300 and 500 ms after stimulus-onset. These are similar to time-window definitions 
that have been used in previous studies (Buzzell et al., 2014; Luijten et al., 2011).  
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Figure 4.1. Grand averaged ERPs for 4 NS at baseline, elicited from the image slideshow 
task, 0.1–30.0 Hz (top) and 1.0–30 Hz (bottom) for FZ (left) and PZ (right). Picture 
categories: neutral (navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical 
grey line marks stimulus onset (i.e., 0 ms). 
ms
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Figure 4.2. Grand averaged ERPs for 9 S at baseline, elicited from the image slideshow task, 
0.1–30.0 Hz (top) and 1.0–30 Hz (bottom) for FZ (left) and PZ (right). Picture categories: 
neutral (navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 4.3. Grand averaged ERPs for 5 NS at baseline, elicited from the Go/NoGo task, 0.1–
30.0 Hz (top) and 1.0–30 Hz (bottom) FZ (left) and CPZ (right). Categories: NoGo (navy), 
Go (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
ms
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Figure 4.4. Grand averaged ERPs for 9 S at baseline, elicited from the Go/NoGo task, 0.1–
30.0 Hz (top) and 1.0–30 Hz (bottom) for FZ (left) and CPZ (right). Categories: NoGo 
(navy), Go (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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4.2.3 Filtering differences between smokers and non-smokers: Interpreting the ERP 
results 
By the time online filtering had been changed from 1.0–40.0 Hz to DC–200.0 Hz most 
of non-smoker data had been recorded. This meant that most of non-smoker data was 
recorded online with a band pass of 1–40 Hz, while most of smoker data was recorded online 
with a bandpass of DC–200 Hz. Although it seemed that offline filtering made these 
equivalent, advice from Compumedics suggested that the data might not be entirely 
comparable. Because of this we compared group averages for each task (Go/NoGo and image 
slideshow) for participants that were to be included in the final analyses (12 NS and 37 S, 
including a mixture of EEG recorded with online filter of 1.0–40.0 Hz and DC–200.0 Hz) 
with groups averages of some recordings that were filtered online using only a DC–200 Hz 
bandpass (5 NS and 9 S). Visual inspection was made to see if differences between groups 
remained when groups had identical online and offline filtering. This revealed that amplitudes 
differences between groups remained, but difference in latencies of LPP components seen in 
the main comparison, disappeared when filtering was identical (Figures 4.5 & 4.6). This 
suggested that any latency differences between groups might be due to the difference online-
filtering parameters but this did not affect us, as we did not plan to measure latencies. 
Because amplitude group differences remained when filtering was identical, we were 
confident that such results were a true reflection of group differences. While measurement of 
latency was not planned, these differences were still important in determining how to define 
ERP time windows, especially the LPPs. After careful examination of individual ERPs, it was 
decided that the time-windows defined above were the most appropriate in our study. 
See Appendix J for ERP figures (7.2–35) elicited at each analysed electrode for image 
slideshow and Go/NoGo tasks at baseline and follow-up. 
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Figure 4.5. Grand averaged ERPs at FZ, 1.0–30 Hz, at baseline. Amplitude group differences 
including both 0.1 and 1.0 Hz online filtering, 12 NS (top left) and 37 S (top right) remain 
when 1.0 Hz online filtering is removed, 4 NS and 9 S (bottom). Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset (i.e., 0 ms). 
ms












EEG file: Neu.S.avg  Recorded : 08:29:30 18-Jun-2015




Printed : 21:05:50 07-Mar-2016
ms












EEG file: Neu.NS.avg  Recorded : 10:02:11 22-Apr-2015




Printed : 21:07:46 7-Mar-2016
ms












EEG file: 5.NS.neu.1Hz.avg  Recorded : 10:29:22 28-Oct-2015




Printed : 21:11:38 07-Mar-2016
ms












EEG file: 9.SM.neu.1Hz.avg  Recorded : 08:26:16 02-Oct-2015




Printed : 21:12:56 07-Mar-2016
Figure 4.6. Grand averaged ERPs at PZ, 1.0–30 Hz, at baseline. Amplitude group differences 
including both 0.1 and 1.0 Hz online filtering, 12 NS (top left) and 37 S (top right) remain when 
1.0 Hz online filtering is removed, 4 NS and 9 S (bottom). Picture categories: neutral (navy), 
pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks stimulus onset 
(i.e., 0 ms). 
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4.3 Baseline analyses 
4.3.1  Attentional and emotional image processing bias: Image slideshow task 
4.3.1.1 P3  
Multiple comparisons tests showed significant differences at F1, ηp2 = 0.065, 
showing decreased P3 for smoking images relative to neutral images in smokers, qN-K = 4.48, 
p = 0.010, but not for non-smokers qN-K = 3.58, p = 0.156, Figure 4.7. Other categories did not 
elicit significantly different amplitudes to the neutral category for either group. Neutral and 
smoking images appeared to elicit larger amplitudes for non-smokers compared to smokers, 















Other significant effects were observed at CZ, ηp2 = 0.045. Smokers showed lower P3 
compared to non-smokers for neutral, qN-K = 3.85, p = 0.038, pleasant, qN-K = 6.77, p < 0.001, 
and smoking images, qN-K = 5.60, p = 0.002, but no difference for unpleasant images, qN-K = 
1.96, p = 0.169, Figure 4.8. There were no differences between neutral and other categories 























Figure 4.7. P3 amplitude at F1. Amplitude was lower in response to smoking images 



















Significant effects were also observed at CPZ, ηp2 = 0.762, showing that smokers 
elicited significantly lower P3 for pleasant images than non-smokers, qN-K = 4.37, p = 0.048, 
Figure 4.8. There were also significantly lower amplitudes for pleasant images relative to 
unpleasant images in smokers, qN-K = 4.36, p = 0.029, while no difference for non-smokers, qN-
K = 2.05, p = 0.319, Figure 4.9. There was a trend for P3 in response to pleasant images to be 
larger than that for neutral images in non-smokers, however this was not significant, qN-K = 






























Figure 4.8. P3 amplitude at CZ. Smokers showed smaller P3 amplitudes than non-smokers in 
response to all stimuli except unpleasant. Values represent means and ±SEM. * = p < 0.05, ** 




















4.3.1.2 Early LPP 
Early LPP was measured at F1, F2, FZ, FCZ, and CZ. It was not measured at CPZ or 
PZ because the time window crossed over to an adjacent negative component, which could 
not be definitively related to the LPP. Multiple comparisons for E.LPP showed significant 
differences at F2, ηp2= 0.023. Figure 4.10 suggests that smokers showed lower E.LPP 
amplitudes than non-smokers for smoking, pleasant, and neutral images. However this was 
only significant for smoking images, qN-K = 4.25, p = 0.036. Smokers also showed lower 
amplitudes for smoking stimuli compared to neutral stimuli, which only just reached 








Figure 4.9. P3 amplitude at CPZ. Smokers showed smaller P3 amplitudes for pleasant stimuli 
compared to non-smokers and to P3 elicited by unpleasant stimuli in smokers. Values 
































4.3.1.3 Late LPP  
Multiple comparisons at P2, ηp2 = 0.045, showed lower L.LPP amplitudes for 
unpleasant stimuli compared to neutral stimuli for non-smokers, qN-K = 4.79, p = 0.005, but 
not smokers, qN-K = 0.23, p = 0.984, Figure 4.11. No other significant differences were found 
within groups or between groups, but there was a trend for amplitudes to be lower in response 































Figure 4.11. L.LPP amplitude at P2. Lower amplitudes for were observed for unpleasant 
compared to neutral images but in non-smokers only. Values represent means and ± SEM. ** 
= p < 0.01. 
** 
Figure 4.10. E.LPP amplitude at F2. Smokers showed lower E.LPP amplitudes for smoking images 
compared to that elicited in non-smokers and to amplitudes for neutral images elicited in smokers. 
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Figure 4.12 suggests that L.LPP amplitude is decreased for smoking images in 
smokers compared to non-smokers at F2, ηp2 = 0.014, but this was not significant, qN-K = 











4.3.2 Inhibitory control: Go/NoGo task 
4.3.2.1 P3  
P3 was analysed at FCZ, CZ, C1, C2, and CPZ, as P3 is known to be largest in these 
regions (Luijten et al. 2011). Multiple comparisons showed small but significant effects at C1, 
ηp2 = 0.000. Smokers showed significantly higher amplitudes for NoGo stimuli compared to 
Go stimuli, qN-K = 4.45, p = 0.008, however non-smokers showed no difference between these 
2 categories, qN-K = 2.21, p = 0.272, Figure 4.13. No differences were observed between 




























Figure 4.12. L.LPP amplitude at F2 suggests lower amplitudes in smokers compared to non-
smokers for smoking images, but this was not significant. Values represent means and ± SEM. 














Multiple comparisons of N2 showed significant differences at CZ, ηp2 = 0.102. N2 
elicited for NoGo stimuli was no different to that elicited for Go stimuli in smokers or non-
smokers. Smokers showed significantly enhanced N2 compared to non-smokers for Go 
stimuli, qN-K = 8.85, p < 0.001, and NoGo stimuli, qN-K = 8.36, p < 0.001, Figure 4.14. 
Another significant interaction effect was observed at F1, ηp2 = 0.127, showing 
opposite effects to those at CZ. At F1, smokers showed lower N2 amplitudes for NoGo 
stimuli than non-smokers, qN-K = 4.35, p = 0.018. In addition, non-smokers showed 
significantly larger N2 for NoGo stimuli than Go stimuli, qN-K = 6.05, p = 0.0003, while 























Figure 4.13. P3 amplitudes at C1. Lower P3 amplitudes were observed in response to Go 
compared to NoGo stimuli for smokers only. Values represent means and ±SEM. ** = p < 0.01. 
** 










































Figure 4.15. N2 amplitude at F1 shows lower NoGo N2 amplitude in smokers compared to 
non-smokers. Plot also shows difference between Go and NoGo stimuli for non-smokers 



















Figure 4.14. N2 amplitude at CZ shows higher amplitudes for smokers compared to non-
smoker for Go and NoGo stimuli. Values represent means and ±SEM. *** = p < 0.001. 
******
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4.3.2.3 Accuracy and reaction time 
Multiple comparisons showed significant differences in accuracy on the Go/NoGo 
task, ηp2 = 0.010. Smokers and non-smokers were significantly less accurate responding to 
NoGo stimuli than Go stimuli with qN-K = 10.49, p < 0.001, and qN-K = 4.60, p = 0.006, for 
smokers and non-smokers, respectively, Figure 4.16. There was a trend for smokers to have 
lower accuracy in response to NoGo stimuli than smokers, however this was not significant, 

















There were also significant differences in reaction time at baseline, ηp2 = 0.030. 
Smokers and non-smokers both had significantly faster reaction times in response to false 
alarms (NoGo) compared to correct hits (Go), with qN-K = 17.74, p < 0.001, and qN-K = 10.77, p 
< 0.001, for smokers and non-smokers, respectively, Figure 4.17. No differences were found 





Figure 4.16. Accuracy on the Go/NoGo task shows that smokers and non-smokers were both 
less accurate in response to NoGo stimuli than Go stimuli. Values represent means and ±SEM. 































4.3.2.4 Mindfulness: FFMQ 
Baseline analyses of the FFMQ showed no differences between groups for any of the 
five facets of mindfulness at baseline (Table 4.8). 
Table 4.8: Five facets of mindfulness (FFMQ) at baseline. Man-Whitney tests show no difference 
between smokers and non-smokers. 




U z p r 
Observing 29 27 199.00 -0.92 0.357 -0.13 
Describing 16 15 232.50 -0.18 0.858 -0.03 
Awareness 27 24 200.50 -0.89 0.375 -0.13 
Non-judging 26 28 205.00 -0.79 0.431 -0.11 
Non-reactivity 24 22 195.50 -0.99 0.318 -0.14 
Figure 4.17. Reaction time on the Go/NoGo tasks shows that smokers and non-smokers 
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4.3.2.5 Craving and smoking status 
One participant had missing baseline data for cigarettes smoked/day and one had 
missing baseline data for QSU.  Average rating on QSU-brief was M = 37.78, SD = 13.69 
with a range of 10–63, and average number of cigarettes smoked/day was M = 16.61, SD = 
6.58.  
There was no significant correlation between craving and smoking status at baseline, 
among all smokers recorded at baseline, r = 0.035, p = 0.420, and when only the compliant 
smokers were analysed, r = 0.282, p = 0.200. 
4.4 Follow-up analyses 
4.4.1 Attentional and emotional image processing bias: image slideshow task 
4.4.1.1 P3  
Figure 4.18 shows multiple comparisons at F1, ηp2 = 0.042. The figure suggests that 
P3 in response to pleasant images, increased at follow-up for smokers, but this was not 
significant, qN-K = 3.42, p = 0.373. There also looked to be lower amplitudes for smoking 
images compared to neutral images in non-smokers at Session 2, but this was also not 
significant, qN-K = 3.87, p = 0.158. In contrast to baseline results, smokers showed no 
difference in amplitude for smoking images compared to neutral images at Session 2, qN-K = 










































































Figure 4.18. P3 amplitudes at F1 for Sessions 1 and 2 for individual categories in smokers 
and non-smokers showed no significant effects. Values represent means and ±SEM. 
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Multiple comparisons at CZ, ηp2 = 0.119, show that non-smokers’ responses to 
pleasant images decreased at follow-up, qN-K = 6.80 p = 0.001, while there was no change in 
amplitude for smokers, qN-K = 2.17, p = 0.902, Figure 4.19. In contrast to baseline there was 
no difference in amplitude for P3 elicited by pleasant images compared to neutral images at 
Session 2 for non-smokers, qN-K = 2.85 p = 0.539. Likewise, there was no difference between 
P3 elicited for pleasant images between smokers and non-smokers at Session 2, qN-K = 2.95 p 
= 0.591, or for any other category. 
Figure 4.20 shows multiple comparisons at CPZ, ηp2 = 0.125, suggesting decreased 
P3 for pleasant images in non-smokers at Session 2 compared to Session 1, however this was 
not significant, qN-K = 4.07, p = 0.224. In contrast to baseline analyses, there was no difference 















































































Figure 4.19. P3 amplitudes at CZ for Sessions 1 and 2 for individual categories in smokers and 
non-smokers. P3 for pleasant images decreased at time 2 for non-smokers, while there was no 
change for smokers. Values represent means and ±SEM. *** p < 0.001 
*** 
















4.4.1.2 Early LPP  
Figure 4.21 shows multiple comparisons for early LPP at follow-up at F2, ηp2 = 
0.014, suggesting that E.LPP increased for pleasant images in smokers at Session 2 compared 
to Session 1, however this was not significant, qN-K = 1.69, p = 0.632. In contrast to baseline, 
there was no significant different between smokers and non-smokers at Session 2 for E.LPP 












Figure 4.20. P3 amplitudes at CPZ for Sessions 1 and 2 for individual categories in smokers 

































































Figure 4.21. E.LPP amplitudes at F2 for Sessions 1 and 2 for individual categories in smokers 
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4.4.1.3 Late LPP  
Figure 4.22 shows the multiple comparisons at FCZ, ηp2 = 0.011. The figure suggests 
that smokers had increased L.LPP for pleasant images at follow-up compared to baseline, 
however this was not significant, qN-K = 2.77, p = 0.787. It looked like smokers had a larger 
L.LPP than non-smokers in response to pleasant images at Session 2, however this was also 
not significant, qN-K = 1.91, p = 0.911. Similar effects looked to have appeared at F2, ηp2 = 
















Figure 4.24 shows the multiple comparisons at P2, ηp2 = 0.075, suggesting that 
smokers showed lower L.LPP at Session 2 in response to all categories, compared to non-
smokers. This effect was only significant for smoking images, qN-K = 7.19, p < 0.001, and 
nearly for pleasant images, qN-K = 4.66, p = 0.093, but not for neutral, qN-K = 2.22, p = 0.702, 






Figure 4.22. L.LPP amplitudes at FCZ for Sessions 1 and 2 for individual categories in smokers 





























































































































































Figure 4.24. L.LPP amplitudes at P2 for Sessions 1 and 2 for individual categories in smokers 
and non-smokers. Smokers had blunted L.LPP for smoking images at Session 2 compared to 
non-smokers. Values represent means and ±SEM. *** = p < 0.001 
*** 
Figure 4.23. L.LPP amplitudes at F2 for Sessions 1 and 2 for individual categories in smokers 
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4.4.2 Inhibitory control: Go/NoGo task  
4.4.2.1 P3 ERPs 
Multiple comparisons showed significant differences at CPZ, ηp2 = 0.051. Smokers 
showed increased P3 amplitudes for NoGo stimuli, qN-K = 6.18, p = 0.005, and Go stimuli, qN-K 
= 4.12, p = 0.039 at Session 2 compared to Session 1, Figure 4.25. Non-smokers showed a 
trend for a decrease in P3 at Session 2 for NoGo stimuli, qN-K = 3.52, p = 0.093, and no change 
for Go stimuli, qN-K = 2.55, p = 0.301. At Session 2 P3 was significantly larger for NoGo 
stimuli compared to Go stimuli in smokers, qN-K = 4.12, p = 0.040, but there was no difference 













4.4.2.2 N2 ERPs 
Multiple comparisons showed significant interactions at F1, ηp2 = 0.198. N2 
amplitudes were significant reduced at Session 2 compared to Session for NoGo stimuli, qN-K 
= 7.06, p = 0.001, and Go stimuli, qN-K = 5.03, p = 0.027 in non-smokers, Figure 4.26. There 
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Figure 4.25. P3 amplitude at CPZ for Go and NoGo stimuli in smokers and non-smokers. 



















Other effects occurred at F2, ηp2 = 0.149. At Session 2 smokers showed larger N2 
amplitudes for NoGo stimuli than non-smokers, qN-K = 4.97, p = 0.029, Figure 4.27. Non-
smokers also showed a significant decrease in N2 for NoGo stimuli at Session 2 compared to 
Session 1, qN-K = 5.63, p = 0.008. Figure 4.27 suggests a slight increase of NoGo N2 at 













Figure 4.26. N2 amplitudes F1. N2 decreased at Session 2 for non-smokers for both Go and 
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Figure 4.27. N2 amplitudes F2. NoGo N2 for non-smokers decreased at Session 2 compared 
to Session 1, and was also smaller than NoGo N2 for smokers at Session 2. Values represent 
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4.4.2.3 Accuracy and reaction time 
Figure 4.28 shows the main comparisons for accuracy, ηp2 = 0.015. At Session 2 
smokers had significantly lower accuracy for NoGo stimuli than non-smokers, qN-K = 8.30, p < 
0.001. At Session 2, accuracy was greater for Go compared to NoGo stimuli in both smokers, 
qN-K = 13.68, p < 0.001, and non-smokers, qN-K = 9.02, p < 0.001. There was also a trend for 
NoGo accuracy to decrease for smokers at follow-up, but this did not reach significance, qN-K 
= 2.85, p = 0.057. There was no change in NoGo accuracy at follow-up for non-smokers, qN-K 
= 0.54, p = 0.706. There was also no change in accuracy for Go stimuli in either group. 
Figure 4.29 shows multiple comparisons for reaction time at follow-up, ηp2 = 0.030. 
Reaction time was slower at Session 2, in response to Go stimuli compared to NoGo stimuli 
for both smokers, qN-K = 19.15, p < 0.001, and non-smokers, qN-K = 22.64, p < 0.001. There 
























Figure 4.28. Accuracy in the Go/NoGo task for Sessions 1 and 2, for smokers and non-
































4.4.2.4 Mindfulness: FFMQ 
	  
Analyses of FFMQ facets showed no significant changes at follow-up among smokers 
or non-smokers (Table 4.9). 
4.4.2.5 Craving and smoking status 
There was a significant drop in smoking status (cigarettes/day) at 1-2 month follow-up 
among those who completed at least 70% of the app and came to their EEG session (M at 
baseline = 37.9, SD = 18.9, M at 1-2 month follow-up = 8.20, SD = 6.60). This difference, 
29.7, 95% CI [17.0 – 42.4], was significant t(9) = 5.29, p = 0.001, and presented a large effect 
size, d = 1.67 (Figure 3.38). 
Conversely, there was no significant decline in craving (QSU-brief) at 1-2 month 
follow-up, baseline Mdn = 33, follow-up Mdn = 30, z = -1.20, p = 0.230, r = -0.36. Follow-up 
ratings of craving ranged from 10–62. 
Among smokers there was a medium correlation between craving and smoking status 




Figure 4.29. Reaction time in the Go/NoGo task for Sessions 1 and 2, for smokers and non-
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Table 4.9. Values for the Five Facets of Mindfulness Questionnaire (FFMQ) did not change at 








z p r 
NS Observing 29 28 -1.31 0.191 -0.28 
S Observing 27 29 -0.35 0.724 -0.07 
NS Describing 16 16 -0.11 0.916 -0.02 
S Describing 14 15 -0.60 0.549 -0.12 
NS Awareness 27 25 -0.16 0.877 -0.03 
S Awareness 23 27 -1.23 0.218 -0.26 
NS Non-judging 26 27 -1.05 0.293 -0.22 
S Non-judging 28 29 -1.07 0.285 -0.23 
NS Non-reactivity 24 23 -1.06 0.288 -0.23 




















Figure 4.30 Smoking status (cigarettes/day) was lower at Session 2 than Session 1. Values 
represent means and ±SEM. *** = p < 0.001. 
*** 
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5  Discussion 
The aim of the current study was to test the effectiveness of a potential new mainstay 
treatment for smoking-cessation delivered via smartphones and to elucidate the potential 
mechanisms of a mindfulness-based intervention for smoking-cessation.  
Findings show promise for using a mindfulness-based intervention for smoking-
cessation in terms of reducing cigarette consumption at follow-up although more research is 
needed to isolate its proposed mechanisms. Baseline and follow-up findings will be discussed 
first, then limitations, and proposed changes for a larger-scale study. 
5.1 Baseline 
The first aim of our study was to replicate an image processing bias to smoking cues, 
and deficits in behavioural and neural markers of inhibitory control at baseline. We also 
expected to find no difference between smokers and non-smokers for image processing of 
pleasant, neutral and unpleasant stimuli at baseline. We observed no smoking-related image 
processing bias and found blunted processing of all types of stimuli, except unpleasant 
stimuli, in smokers relative to non-smokers. Smokers also showed a trend for reduced 
accuracy in the Go/NoGo task and showed reduced NoGo N2 (marker of conflict monitoring) 
relative to non-smokers, but no significant differences were observed in NoGo P3 (marker of 
motor inhibitory control).  
5.1.1 Image slideshow task 
We expected a smoking-related processing bias in smokers as a reflection of drug-
related incentive salience, which may be implicated in the maintenance of addiction. The lack 
of this effect in the current study was incongruent with our hypothesis and with past literature 
(Littel & Franken, 2007, 2011; McDonough & Warren, 2001; Minnix et al., 2013) and 
indicates, that smokers in our study did not exhibit attentional bias for smoking cues. 
Furthermore, smokers in the current study had a blunted response to smoking images, 
compared with neutral images in smokers, and to smoking images in non-smokers. There is 
evidence that suggests heavier smokers show less attentional bias than light smokers, at least 
behaviourally (Hogarth, Mogg, Bradley, Duka, & Dickinson, 2003), but this is unlikely to be 
the cause of our unexpected results, as smokers in the current study showed similar nicotine 
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dependence and daily smoking status (number of cigarettes smoked/day) to those in previous 
studies. Also, even though smokers in the current study abstained for substantially longer 
before testing than those in previous studies, this is unlikely to account for our different 
results, as McDonough & Warren (2001) have shown that abstinence does not affect P3 
amplitude. Abstinence is also unlikely to affect the LPP. While no study has tested effects of 
abstinence on the LPP, it seems likely that factors affecting a lack of smoking-related image 
processing bias would be the same for both P3 and LPP, because they are closely-related 
components.  
An alternative explanation for the lack of smoking-related image processing bias 
could be that participants became habituated to the smoking images. While potential for 
habituation of P3 and LPP has not been investigated, it may have occurred in the current 
study. This could be because the content of smoking images was very similar (often a close-
up of a cigarette between pursed lips), which contrasts to the varied content in other image 
categories (e.g., night, day, people, objects, one person, several people etc.). This does not 
explain why the blunting was specific for smokers, however, image processing bias to 
smoking-cues may have been more likely in the current study if a greater variety of content 
was used within the smoking category (e.g., people smoking and images of common NZ 
cigarette packets).  
We also did not expect neutral images to elicit similar P3, and LPP amplitudes in 
response to pleasant and unpleasant categories. Perhaps the available normed ratings were not 
appropriate for the tested population. Neutral images may have elicited a stronger valence and 
arousal in participants of the current study than what was indicated in the normed values. 
Conversely, affective images may have elicited a weaker valence. 
Another potential explanation for the lack of processing separation between neutral 
and affective categories is that categories were not controlled for luminosity, contrast and 
spatial frequencies as it has been in other studies including Blakemore, Rieger, & Vuilleumier 
(2016). Within the current study, neutral images typically had a higher contrast than images 
from other categories. While no research has tested whether these image-related variables 
affect the P3 and/or the LPP, previous research has shown that pictures within the IAPS can 
vary in spatial frequency, and suggest that this could affect results in studies which test 
emotional influence on visual processing (Delplanque, N’diaye, Scherer, & Grandjean, 2007). 
Delplanque et al. (2007) suggest that when using the IAPS, picture categories should be 
controlled for on spatial frequency. Future studies are needed to confirm whether contrast, 
spatial frequency and luminosity affect the P3 and LPP. 
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In contrast to Aim 3 and results of Minnix et al. (2013), the current study showed 
reduced image processing in smokers relative to non-smokers for all categories except 
unpleasant. This was shown by reduced P3 for neutral, pleasant and smoking categories at 
baseline in smokers compared to non-smokers. The pattern also appeared in graphs for early 
and late LPP, although these were not significant. Because mean amplitudes of LPP were a lot 
smaller than those for P3, it is possible that we did not have enough power to detect 
differences. It is intriguing that smokers had a blunted processing to all types of stimuli 
except unpleasant and that smokers showed greater P3 amplitudes for unpleasant stimuli 
compared to pleasant stimuli. Because arousal for pleasant and unpleasant stimuli was 
matched, results suggest that unpleasant stimuli were more salient to smokers than pleasant 
stimuli. This could be because smokers were required to abstain from nicotine for at least 8 
hours prior to the EEG session. According to Koob & Le Moal (2001) acute withdrawal from 
nicotine would have produced a state of anhedonia. It is possible that this made smokers more 
sensitive to unpleasant stimuli than if they were satiated. This could also explain why smokers 
in Minnix et al. (2013), who were asked to “smoke normally” before the EEG session, 
showed no differences in processing to neutral, pleasant and unpleasant stimuli, compared to 
non-smokers. Although McDonough & Warren (2001) have shown that abstinence does not 
alter P3 in response to smoking images, there is no evidence to suggest that it does not alter 
responding to pleasant and unpleasant images. Future research should test the effects of 
abstinence on processing of affective stimuli in smokers. 
Although this blunted processing did not occur in the study by Minnix et al. (2013), 
which compared smokers with non-smokers, it has been observed in another study, which 
compared different “clusters” of smokers. In Versace et al. (2012) results of smokers were 
separated into 2 clusters based on sensitivity to pleasant stimuli. The cluster of smokers who 
were less responsive to pleasant stimuli were less likely to be abstinent at follow-up (Versace 
et al., 2012). This finding, in combination with our results, suggests that measuring ERP 
responses to intrinsically affective stimuli is just as useful as measuring that in response to 
smoking-related stimuli. 
5.1.2 Go/NoGo task 
Parts of Aim 2, relating to the Go/NoGo task, were supported by the results. The 
current study showed a trend for lower accuracy for NoGo stimuli on the Go/NoGo task in 
smokers compared to non-smokers, which was supported by lower NoGo N2 amplitudes at 
F1. These results follow studies of Luijten et al. (2011) and Buzzell et al. (2014). 
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Interestingly, we showed a trend for differences in behavioural accuracy while Buzzell et al. 
(2014) did not. It was suggested by Buzzell et al. (2014) that they did not observe differences 
in behaviour because they tested smokers with low nicotine dependence. They posed that N2 
is a more sensitive measure of inhibitory control than behaviour and that behavioural task 
deficits would be more apparent in smokers with greater levels of dependence (Buzzell et al. 
2014). The average level of nicotine dependence of participants in the current study was 
moderate, which could explain why we showed differences in behaviour while Buzzell et al. 
(2014) did not. Unexpectedly, we saw higher N2 for both Go and NoGo stimuli at CZ in 
smokers compared to non-smokers. This finding is perplexing and may have little meaning 
considering that the average N2 at CZ was nearly half the size of that at frontal electrodes. 
Because N2 is more prominent at frontal electrodes in both our study and previous studies, 
any changes at F1 are likely to be more reliable than those at CZ. Alternatively, this could 
reflect inefficient recruitment of appropriate neural resources in smokers, which future 
research should explore. 
An aim relating to the Go/NoGo task, which was not supported by our findings, was 
that smokers would show reduced NoGo P3 amplitudes compared to smokers. This is not 
surprising as neither Luijten et al. (2011) nor Buzzell et al. (2014) showed any group effects 
on NoGo P3. This could suggest that NoGo P3 is a less sensitive measure of inhibitory 
control than N2, or that unlike other impulsive populations (Luijten et al. 2011) NoGo P3 is 
not different in smokers compared to non-smokers. 
An alternative explanation to observing no group effects for NoGo P3 could be that 
we did not measure the correct component. This could be indicated by observations of a large, 
unanticipated, positive peak occurring between 600–800 ms after Go and NoGo stimuli. This 
was observed at frontal through to parietal electrodes and was highest in response to NoGo 
stimuli, which follows the typical pattern of the Go/NoGo P3. The average peak amplitude of 
this potential was much higher than that occurring between 300–500 ms (analysed P3), which 
could suggest that in the current study, Go/NoGo P3 peaked within a later time-window. 
Subsequently, this could suggest that we did not analyse the true Go/NoGo P3, which may 
explain why we found no group differences at baseline. However, no previous literature has 
reported Go/NoGo P3 later than 500 ms. Because of this we could not reliably categorise a 
positive peak between 600–800 ms as the Go/NoGo P3 and so we decided not to analyse it 
statistically.  
Future studies should report unexpected positive components that are observed 600 ms 
post-stimulus in the Go/NoGo task. This could help confirm whether it is possible for the 
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Go/NoGo P3 to occur this late, or if positive peaks at this latency reflect a separate neural 
process. 
5.2 Follow-up 
All of our hypotheses (1–7, see section 2.2) and Aim 4 were related to follow-up 
results. We hypothesised that those exposed to Craving to Quit would show a reduced 
smoking-related processing bias, increased processing to neutral and affective (pleasant and 
unpleasant) stimuli, and would have increased NoGo N2, NoGo P3, and NoGo accuracy. We 
found no significant reduction in smoking-related image processing bias, and no change in 
processing to neutral and affective stimuli within smokers. Smokers showed a significant 
increase in P3 at follow-up for both Go and NoGo stimuli while non-smokers showed no 
change. There was no change for smokers’ N2 but a significant decrease for NoGo and Go N2 
in non-smokers at follow-up. There was no change in accuracy on the Go/NoGo task for non-
smokers but a trend for decreased NoGo accuracy for smokers.  
5.2.1 Go/NoGo 
At Session 2, smokers showed significantly lower accuracy for NoGo stimuli in the 
Go/NoGo task than non-smokers. Because this was only a trend at baseline, results suggest 
that smokers were worse at the task at follow-up. This is supported by a trend for decreased 
NoGo accuracy in smokers at follow-up while there was no change in accuracy for non-
smokers. Hypothesis 1 of increased behavioural markers of inhibitory control was therefore 
not supported.  
Although smokers’ amplitudes for NoGo N2 at follow-up were not significantly 
different to those at Session 1, they were significantly larger than those of non-smokers’ at 
follow-up. This is because non-smokers showed significantly decreased N2 amplitudes for 
both Go and NoGo stimuli at follow-up compared to baseline. This could reflect a decrease in 
neural resources needed to perform the task again, with a similar accuracy. In contrast to 
decreased N2 in non-smokers, there was an increase in P3 for Go and NoGo stimuli at follow-
up among smokers. This partially supports Hypothesis 2, but is incongruent with smokers’ 
trend for decreased NoGo accuracy. Following a similar interpretation to the results of non-
smokers, increased P3 in smokers may reflect increased neural resources required to perform 
the Go/NoGo task at a similar accuracy to baseline. This could be due to a reduced capacity of 
inhibitory control during a quit attempt, as quit attempts require continual inhibition of 
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smoking behaviour. This could explain the discrepancy between behavioural and neural 
results in smokers. Another interpretation of our results could be that changes in NoGo P3 
amplitudes are precursors for changes in accuracy. As suggested by Buzzell et al. (2014), 
ERPs may be more sensitive markers of inhibitory control than behaviour. Future studies are 
needed to test these interpretations. Such studies should test inhibitory control in participants 
who attempt to quit without Craving to Quit and include a longer-term EEG follow-up. If 
participants who attempt to quit with no intervention show greater deficits in accuracy as well 
as NoGo N2 and P3 compared to those who do use the app, this could suggest that Craving to 
Quit can mitigate deficits of inhibitory control during a quit-attempt.  
5.2.2 Image slideshow 
Other than reduced P3 for pleasant images in non-smokers at follow-up, no significant 
ERP changes occurred in response to the slideshow between sessions meaning that results did 
not support Hypothesis 3 or 4. Despite lack of significance, Figures 4.22 and 4.23 indicate 
striking differences in late LPP at frontal electrodes between sessions for smokers, which 
cannot be ignored. In the same direction as Hypothesis 3, there was a non-significant 
tendency for late LPP amplitudes to increase at Session 2 in smokers for neutral and affective 
categories. Results may have failed to reach significance because, as with baseline, mean 
amplitudes for LPP were very small. One of the reasons of these small amplitudes could be 
due to the high-pass filtering that we used, which was higher in comparison to previous 
studies. This is visible in Figure 4.1, comparing a high-pass filter or 0.1 Hz with 1.0 Hz. 
Correcting for multiple comparisons (up to 16) may have also reduced our ability to detect 
differences, but this method was chosen to reduce the likelihood of committing Type 1 error. 
These striking Figures suggest that a design with greater statistical power might reveal this 
potential mechanism of mindfulness, i.e., increased neural processing related to increased 
awareness.  
Figure 4.25, at P2, showed an opposite direction of effect to frontal electrodes, with 
non-smokers showing a non-significant tendency for late LPP to increase at follow-up, while 
smokers showed no change. While the most obvious reason for this separation is that we used 
different time-windows within our late LPP definition, it is also possible that the different 
electrode locations reflect activity generated from different brain areas. In support of this, 
both Liu et al. (2012) and Sabatinelli et al. (2013) have shown that both cortical and 
subcortical areas can be activated within the LPP time frame. Because of the proximity, 
frontal electrodes may reflect cortical activity, related to cognitive processing and attention. 
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Likewise, parietal electrodes could reflect subcortical activity related to emotional reactivity. 
It is possible that increased expectancy from seeing the images twice made non-smokers more 
“emotionally reactive” at Session 2 than at Session 1, which was shown as a tendency for 
increased L.LPP at P2.  Increased awareness with mindfulness may have increased cognitive 
processing and attention indicated by a tendency for increased frontal L.LPP in smokers. 
Increased cognitive processing and attention may then have a top-down effect on emotional 
reactivity, mitigating any expectancy-related increases of L.LPP at P2.  
Support of this ability to illustrate top-down emotion-regulation with EEG comes from 
Littel & Franken (2011). Compared to passive viewing, cognitive reappraisal of smoking 
images increased frontal LPP activity but with no differentiation between types of reappraisal, 
i.e., focusing on the positive feelings associated with smoking (“enhance”) gave the same 
LPP amplitudes as “distraction”. In contrast to frontal electrodes, using “distraction” over 
“enhance” techniques was associated with lower parietal LPP. This could represent that 
continued cognitive processing during reappraisal increases frontal LPP, irrespective of 
reappraisal type, whereas parietal LPP can decrease, dependent on reappraisal type.  Further 
research is needed to confirm this suggested separation of frontal and parietal LPP and the 
proposed top-down emotion-regulation mechanism of mindfulness. 
Although we hypothesised decreased image processing bias for smoking cues in 
smokers compared to non-smokers at follow-up (Hypothesis 4), it was not possible to show 
because there was no image processing bias at baseline. Another reason for not supporting 
this hypothesis is that changes in conditioned stimulus reactivity of smoking-related images, 
are unlikely to be the only factor that can affect P3 and LPP. We even hypothesised that 
because mindfulness encourages an increased awareness to the present moment, this is likely 
to increase P3 and LPP (Hypothesis 3). Therefore any decreases in P3 and LPP, related to 
decreased conditioned responses for smoking stimuli, may be competed by a concurrent 
increase in P3 and LPP, related to increased awareness. From the above discussion, any 
decreases in smoking-related image processing bias would most likely be observed at parietal 
electrodes, which potentially reflect emotional reactivity. We did not show specific decreases 
for the smoking category, which could be due to a combination of a small sample size and the 
small number of people who had completed the whole programme by the second session. 
Future studies could examine the ERP effects of mindfulness for smoking-cessation at a 
longer-term follow-up among participants who fully complete the programme. 
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5.2.3 Mindfulness (FFMQ) 
Hypothesis 5 was that those in the smoking group would have increased mindfulness 
on the FFMQ compared to non-smokers. However, here was no change in any subscale for 
either group, thus this hypothesis is rejected. However, in hindsight it makes sense that 
participants did not change significantly on these facets, as the FFMQ has been used to 
measure “trait mindfulness” (Garland et al., 2012) rather than state mindfulness. Given the 
short length of the study, a state-mindfulness questionnaire may have been more appropriate. 
5.2.4 Smoking and craving 
Our final hypotheses were related to smoking status and craving at 1-2 month follow-
up. Smokers showed substantially reduced smoking status (cigarettes/day) compared to 
baseline but no changes in craving. While this suggests that there was no correlation between 
smoking and craving at follow-up, we did not replicate the “decoupling” of craving and 
smoking observed by Elwafi et al. (2013). In an opposite pattern to Elwafi et al. (2013) we 
found no correlation between craving and smoking at baseline, but a trend for a medium 
correlation at follow-up. Therefore, while we supported Hypothesis 6, results did not support 
Hypothesis 7. The lack of correlation between craving and smoking at baseline may be 
because all smokers might have had similarly high baseline craving due to being required to 
abstain from smoking for 8 hours before their test session (compared to around 1 hour in 
previous studies). Results showed that this was not the case and craving showed a normal 
distribution with values ranging from 10 to 63.  Nevertheless a correlation between baseline 
craving and smoking status may have existed if participants were satiated at the time of 
testing, as in other studies. In hindsight it is not surprising that we did not replicate a 
decoupling. This is because we measured craving and smoking status at about 6-weeks 
follow-up, instead of 4 weeks, as used in Elwafi et al (2013). While Elwafi et al. (2013) 
observed a decoupling at 4-week follow-up, a significant correlation re-emerged at 6 weeks. It 
is unfortunate that we had low compliance on the experience sampling. If we had more 
participants complete this aspect of the experiment we may have been able to show when in 
the programme a correlation between craving and smoking re-emerges.  
5.2.5 Compliance 
A main but unexpected finding in our results was the low compliance rate for the 
intervention, with more than 60% of participants not completing at least 70% of the 
intervention within 2 months of starting. In addition, many people did not answer multiple 
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phone calls, texts, voicemails, or emails regarding continuing use of the app. Of the 
participants who used at least 70% of the app, follow-up rate was high at nearly 85%, and was 
100% for non-smokers.  
A follow-up questionnaire for non-compliant smokers showed that the main reasons 
for not using more of the app was that the exercises were too long and feelings of failure. 
Although the length of daily activities ranged 2–30 min/day the mean length per day of the 
programme was around 6 min (although more was encouraged).  The “Rain” exercise took an 
extra 3 min and could be used each the user had a craving. The perception that the C2Q 
exercises take too long may stem from the fact that quitting smoking using mindfulness 
requires users to set aside time for training (meditation), while skills-training strategies, such 
as cognitive reappraisal, can be integrated into day-to-day life relatively easily. It also may be 
more practical to use a skills-training strategy than a mindfulness exercise when dealing with 
craving out in public. This could be the case at least initially when C2Q users rely on listening 
to an audio recording called the “rain exercise” to mindfully cope with craving. The negative 
impact of the “exercises being too long” relates to findings of Buller et al. (2014) and 
Whittaker, Merry, et al. (2012) who both found that simpler text interventions were more 
effective than use of an app. Smokers may be more likely to engage in an intervention when 
more external guidance is offered and less self-directed practice is required. For example, 
during the day, smokers may be more likely to read a craving tip that is sent to their direct 
inbox than to search for the tip themselves within an app. In addition to this, for a population 
which shows high delay discounting (Secades-Villa, Weidberg, García-Rodríguez, 
Fernández-Hermida, & Yoon, 2014), smokers might find it difficult to practise formal 
mediation, when they are unlikely to receive any immediate benefits.  
Another interesting finding from the non-compliant follow-up questionnaire was that 
half of responders felt that they had “failed the programme” when they missed 1 of more 
days. This indicates that the intervention programme may have been too strict or that the 
participants were sensitive to failure (e.g., from previous quit attempts) or a mixture of both. 
Each smoking lapse within a quit attempt reduces the smoker’s self-efficacy to quit (Shiffman 
et al., 2000). Because it takes a smoker an average of 3–4 quit attempts to succeed (Raw et al., 
1998), it is likely that many smokers in the study had low self-efficacy for quitting, especially 
those who have been smoking for a long time. Because poor self-efficacy has shown to be 
related to relapse (Castro et al., 2014), future interventions for smoking cessation should aim 
at increasing self-efficacy before or during the quit attempt so that smokers are not deterred 
from the quit attempt and engaging in the intervention altogether. 
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5.3 Limitations 
Overall results of the intended analyses show promising evidence of decreased 
smoking status at follow-up, and a potential increase in a neural marker of inhibitory control 
in smokers that used Craving to Quit. However, it is not possible to conclude whether these 
trends of change are related to mindfulness, or to use of a quit-smoking app, or simply, to a 
quit attempt, or some other factor of being in the study. The original study had aimed to 
control for alternative interpretations by including another group receiving an app based on 
skills-training called QuitPal. This group would have received additional messaging to match 
the C2Q group on all components other than mindfulness. This would have allowed for 
interpretations regarding the use of mindfulness in smoking-cessation. Unfortunately poor 
recruitment led to changes in the design, which limits our ability to draw firm conclusions on 
this matter.  
In addition to poor recruitment and needing to drop the study’s comparison 
intervention group, other limitations include specifics of the ERP tasks, different EEG 
filtering, and poor compliance with the intervention. All of these factors somewhat hinder the 
interpretation of our findings and call for a larger-scale version of the study, which are 
discussed below.  
Firstly, categories in the image slideshow should be matched on luminosity and 
contrast, and spatial frequency and smoking images should be chosen with a greater variety of 
content. These changes would reduce the likelihood of other image variables affecting the 
results.  
Secondly, as a whole the image slideshow was very long and participants found it 
difficult to maintain attention. Other experiments were shorter because they used a lower 
number of trials (Dunning et al. 2011) or compared a lower number of categories (Littel & 
Franken, 2007, 2011). However, it was important that the current study had more trials than 
Dunning et al. (2011) to compensate for the low sample size. Using a greater sample size in a 
future study would allow for the number of trials and task time to be reduced.  
Another limitation that could be due to the ERP task design is the notably noisy pre-
stimulus baseline of the Go/NoGo task. This may have derived from averaging late ERP 
components in previous trials, which could have been because we used a shorter inter-trial 
interval (Dong et al. 2010) than was used in previous studies (Buzzell et al. 2014; Luijten et 
al. 2011). It could also indicate a low signal to noise ratio and hence a need for more trials for 
averaging. This complicates the interpretations of the Go/NoGo results and future studies 
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should focus on increasing both numbers of trials for averaging plus longer inter-trial 
intervals. 
Poor recruitment was another major limitation in the study, which led to dropping of 
the comparison intervention group. Difficulties in recruitment were observed at two stages: (i) 
the screening questionnaire, and (ii) recruitment for full participation after sending the 
information sheet. It is likely that many of the people who were eligible from the screening 
survey were put off full participation by reading the expected time involved in the 
information sheet (2 x 2 hr sessions, daily texts, and app compliance over 22 days).  Each 
session was about an hour longer than previous ERP studies (Littel & Franken, 2007, 2011; 
Luijten et al., 2011; Versace et al., 2011) and is generally because we tested two tasks while 
others tested only one. In addition to this, the current study required two sessions while 
others, only one. As well as affecting recruitment, a long test session is likely to stop 
participants from coming back for a second session. In a future study the number of 
electrodes (68) that were recorded in each session could be reduced to only the handful that 
were statistically analysed. This would dramatically reduce session time and allow for more 
focus on reducing impedances.  
Another limitation comes from differences of filtering between experimental groups 
within the current study and between the current study and previous studies. Although our 
results suggest that difference in online filtering did not affect the main amplitude differences 
between groups, latency differences indicate that files were not entirely equivalent. Therefore 
we cannot rule out filtering as a potential confound in our results.   
In addition to the aforementioned limitations, because approximately half of our data 
was recorded using an online high-pass filter of 1.0 Hz, we were unable to match filtering of 
previous studies, which used a high-pass filter of 0.1 Hz (Buzzell et al., 2014; Littel & 
Franken, 2007, 2011; Luijten et al., 2011; Versace et al., 2011). From our results we have 
shown that changing the high-pass filter does affect the ERPs, and especially the late positive 
components elicited by the image slideshow. Although the higher high-pass filter made the 
LPP peaks more recognizable, it removed much of the positive drift that is characteristic of 
the LPP.  Because of this, whether the LPP in our studies was really equivalent to that in other 
studies is questionable. Our interpretations are also limited by assigning different definitions 
to the LPP depending on the electrode position. Similarly, interpretation of the P3 is 
hampered by not being able to measure it at parietal electrode sites, where it is typically most 
prominent (Foti et al., 2009). Future studies are likely to avoid these limitations by recording 
all data online using the widest possible bandpass. 
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The final limitation of the study is that we had a high non-compliance rate (>60%), 
which is substantially greater than that of a previous study (<15%), which also tested 
mindfulness for smoking-cessation (Brewer et al., 2011). Unlike the current study, that by 
Brewer et al. (2011) tested the effectiveness of mindfulness for smoking-cessation in the form 
of group therapy sessions with take home homework and audio recordings. This suggests that 
it is not the mindfulness intervention that led to low compliance, but rather the current 
application of it to smartphones. As suggested above, smokers may benefit more from 
external guidance than self-directed practice and future studies could incorporate external 
guidance/support by testing the app, alongside weekly group mindfulness sessions. This 
would be an inexpensive way to increase compliance through providing users with more 
tangible support.  
As well as addition of group sessions, it might be beneficial to re-label the 
programme’s daily modules as “steps” which, unlike “daily activities,” are not time-locked. 
This would retain any benefits from having a structured programme but allow users to 
progress at a comfortable pace without being put off by feelings of failure early in the 
programme. In turn, the may substantially increase compliance. 
5.4 Concluding comments 
Overall results showed a significant reduction in smoking status (cigarettes/day) for 
smokers who received the Craving to Quit intervention. However, because we had to remove 
an experimental group receiving an alternative intervention, we could not conclude whether 
reductions were due to the app, mindfulness, being in the study, other features associated with 
the intervention, or simply to a quit attempt.  
We found that smokers had reduced NoGo N2 and a trend for reduced NoGo accuracy 
compared to non-smokers at baseline. This trend for reduced accuracy became significant at 
follow-up. Smokers showed increased NoGo P3 at follow-up, but future research is needed to 
determine whether this reflects increased neural markers of inhibitory control preceding 
increased accuracy or increased requirement of neural resources to perform the task during a 
quit attempt, when capacity for inhibitory control may be depleted.  
Smokers showed no smoking-related processing bias at baseline and had blunted P3 
amplitudes compared to non-smokers for all categories, except unpleasant. This could reflect 
increased motivational salience of unpleasant stimuli from anhedonia during nicotine 
withdrawal. This is the first study to show a blunted response for smoking, neutral and 
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pleasant categories in smokers relative to non-smokers. No significant changes occurred at 
follow-up. 
Observed reductions in smoking status may be related to an increased neural marker 
of inhibitory control (NoGo P3) however, future research that compares Craving to Quit with 
an alternative intervention is needed to confirm this. In addition larger sample sizes and a 
wider filter band-pass may reveal significant increases in image processing at frontal 
electrodes after using Craving to Quit.  
It is difficult to know whether Craving to Quit can reduce smoking-related processing 
bias, as smokers did not show this bias to begin with. In addition, effects of increased 
awareness could confound any decreases in smoking-related processing bias. Future studies 
should investigate frontal and parietal differences within the LPP range. Such studies could 
show that activity within these areas reflect separate psychological processes, which could 
add to understanding of the mechanisms involved in mindfulness-based interventions for 
smoking-cessation. 
The study had a range of limitations and a larger study is needed with several 
amendments. These include an alternative and more careful selection of images, dropping of 
number of repeats within the image slideshow, and number of tested electrodes, relabeling 
“days” as “steps” in the C2Q app, a larger sample size (with addition of skills-training group), 
addition of weekly group sessions as an adjunct to each intervention, and longer-term EEG 
follow-ups. In addition to this, all data should be recorded with a broad bandpass filter so that 
comparisons with previous studies can be more readily made. These changes to the design 
would allow for more accurate interpretations of the mechanisms and long-term effectiveness 
of mindfulness as an isolated intervention for nicotine addiction. Using group sessions in 
conjunction with the C2Q app may lead to greater compliance and would still reflect a cost-
effective way to target smoking-cessation on a national scale.   
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7  Appendices 
7.1 Appendix A. Key psychological processes involved in QuitPal and C2Q 
Table 7.1. Key psychological processes involved in QuitPal. Crossed-out text is of app 
components that were to not be used in the original experiment. Italicised text represents an 
added component designed for the original experiment. 
Process App feature 
Positive Reinforcement Reminders 
Saving Goal 
Summary  
Graphs (money saved) 
Tracking 
Tips 




Substitution (gum, lollies) Tips 
Relaxation 
-­‐ Progressive relaxation, yoga (note-no instructions) 
-­‐ Deep breathing 
-­‐ “Quiet time” 
Tips 
Changing routine Tips 
Encourage NRT Tips 
Distraction Tips 
Avoidance of cues Tips 
Social Support Videos 
Tips 
NCI Quitline phone line 
Professional Support NCI Quitline (chat online) 
NCI Quitline phone line 
Awareness of triggers (mood and context) Tracking 
Tips 
Expression of achievement Friend Alert 
Goals Saving goal 
Structured intervention guide Additional texts (see section 
6.9.2). 
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Table 7.2. Key psychological processes involved in C2Q. Crossed-out text is of app components 
that will not used in the experiment 
Process App feature 
Positive reinforcement Quitting pact, morning stats 
Negative reinforcement Costs and benefits video 
Meditation exercises Exercises 
Notifications/reminders Night reflection, morning stats, 
goal reminder, and check-in 
Awareness of triggers (mood and context) Check-in 
Social support and expression of achievement Community 
Professional support Ask the Dr 
Structured intervention guide Daily activities 
Educational videos about how habits are learnt and reinforced 
using analogies 
Daily activities videos 
Goals 
 
Daily goals and quitting pact. 
A constant mentor/guide Videos, daily activities 
Informal mindfulness exercises Check-in, RAIN, mindful 
smoking, noting 
Mantra Day 21 
Quit smoking ceremony Day 21 
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7.2 Appendix B. Advertisement for the study 
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7.3 Appendix C. Human Ethics Committee approval 
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7.4 Appendix D. Information Sheet 
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7.5 Appendix E. Email preparation 
Hi Name, 
 
Here is some information for your first visit:  
 
Preparation:  
In order to get good contact with your scalp for the EEG recordings, please arrive with clean 
and dry hair. When you wash your hair before your visit (on the morning or night before), 
please don’t use conditioner or any extra hair products other than shampoo. If you have a 
brush or comb you might like to bring this with you. I will ask you to brush your hair just 
before we put on the cap. Again, this is to make sure we get good contact with your scalp. If 
you forget to bring a comb we have one in the lab. 
 
Please bring your smartphone for setting up the smoking-cessation app. 
 
Please abstain from using cigarettes and any other form of nicotine (e.g. gum and patches) 
overnight (at least 8 hours) and until after your test session. 
 
Transport and parking:  
If you are driving we have a few parks available by the entrance into the building off Stewart 
St. These are free. There is also a bike stand here (see map). If you are unable to get a park in 
these spots there is a large car park down the road, on St. Asaph St (see map, blue square). 
This charges $2/hour. There are also several bus stops nearby (see map, blue circles). 
 
Getting into the NZBRI building: 
Please enter the building through the Stewart St entrance. At the top of the stairs enter through 
the door to your right and check in with reception. If you have an issues you can text or ring 
me on 022 341 0867. This entrance is locked until 8.30AM. If you are coming before 
8.30AM please ring the doorbell and text or call me to be let in.  
 
Afterwards: 
The EEG procedure involves inserting conductive gel into holes within the cap. This is 
needed to record your brain activity. The gel is harmless but means your hair may look messy 
after the procedure. We have a basin and shower available for you to rinse and/or wash your 
hair. We provide shampoo, conditioner, a fresh towel, and hair dryer for you to use.  
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7.6 Appendix F. Handouts 
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7.6.2 Craving to Quit handout 
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7.7 Appendix G. “Getting back on track” e-mail 
“Hi Name, 
 
I can see you have been finding use of the app. over the past week a little difficult. I know it’s 
hard to give up and find time for the app. 
 
Your use of the app. is really helpful to my research and hopefully to you as well :) 
 
Your participation and use of the app., when you can is greatly appreciated. It will enable me 
to finish the study and add to research on the development of effective treatments for 
smoking-cessation. 
 
• To help get you back on track I suggest you set aside a regular time each day to spend 5 
minutes on completing the “daily activities”. 
• Some people find the “check-in” notifications off-putting so I suggest you turn these off if 
you think that would be helpful. If you want reset the “cut-down” notifications I can 
also send you instructions on how to do this.   
• If you need more motivation, here is a Ted talk by the researcher who helped design the 
app. (Judson Brewer): https://www.youtube.com/watch?v=jE1j5Om7g0U 
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7.8 Appendix H. Debriefing sheet 
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7.9 Appendix I. The alternative intervention that was not included in that 
final experiment: NCI QuitPal  
7.9.1 NCI QuitPal (QuitPal) intervention: Methods summary 
Participants would be asked to set their quit date in the settings for the day they begin 
using the app. This is so that participants receive the positive reinforcement that comes from 
going to the “progress summary” button. This button gives a tally of how much money has 
been saved and how many smoke-free days the participant has had since quit day. Participants 
would be instructed to use the “tracking” function everyday, immediately before sleep and, if 
possible, more often. This records the total number of cigarettes smoked each day, which is 
used for the “Progress summary.”   
The app involves several other buttons that participants can interact with which are 
designed to aid smoking cessation. By clicking on the “videos” button they can add short 
inspirational video messages of loved ones for them to play back later when they need 
motivation to quit. A “My health” button has a list of positive health consequences that occur 
with increasing time of abstinence. The “Saving goals” button allows participants to set 
personalized goals for saving money (e.g., to buy a new phone) and they can check the 
progress of these goals. Using the “Reminder” button, participants can set times for the 
application to alert them with personalized messages to not smoke in high-risk situations. A 
“Friend alert” button allows the participant to post information about how their cessation 
attempts are going on social networking sites such as Facebook and Twitter. Using “NCI 
Quitline,” participants can chat online with a specialist from NCI’s Cancer Information 
Service. “Smoking facts” includes a series of random facts, which are either about the 
negative effects of smoking or positive effects of quitting. “Tips” include suggestions for 
dealing with cravings, including distraction, avoidance substitution, and some which suggest 
slow breathing, relaxation, and meditation. Unlike Craving to Quit, these tips do not give 
specific instructions on how to meditate. Figure 7.1 shows the home screen of the QuitPal 
app, with all features. 
Participants would be encouraged to use the app whenever they feel a craving to 
smoke. This is to encourage a similar amount of time spent interacting with the application as 
in the Craving to Quit condition.  To simulate the list of “daily activities” that are given in the 
Craving to Quit application, we planned to provide 21 days of “daily activities” in QuitPal. 
These suggestions of daily activities would be sent via text (see section 7.9.2). 


















7.9.2 Experience-sampling and QuitPal texts that were designed for the original study 
CONTENT OF DAILY TEXTS 
 
Designed by Stephanie Henderson for “Neural responding in smokers & the effectiveness 
of smartphone-based smoking-cessation aids.” 
8am daily reminder for QuitPal & Craving to Quit (experience-sampling): 
 
C2Q: “Check-in: How much r u craving right now & how many cigarettes did u 
smoke yesterday?” 
 
QuitPal: “Check-in: How much r u craving right now, how many cigarettes did u 
smoke yesterday, how much time did u spend doing activities suggested in “Tips” (& what 
were these)?” 
 
Daily QuitPal texts sent at 8am: 
 
1. Welcome to Day 1 of ur 22-day trial of QuitPal! Today’s activities: Use “Tracking” if 
& when u smoke, read 3 “Facts.” For each craving read tips til u find 1 that is 
applicable. Do ur best to carry it out ☺ 
 
2. QuitPal! D2 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” set a new 
goal using the “Saving Goals” function. For each craving read “Tips” til u find 1 that 
is applicable. Do ur best to carry it out ☺ 
 
3. QuitPal! D3 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” record a 
30s inspirational message of a close friend using the “Videos” module. This is for u to 
play back later. For each craving read tips til u find 1 that is applicable. Do ur best to 
carry it out ☺ 
Figure 7.1. NCI QuitPal app home screen showing all of its features 
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4. QuitPal! D4 activities: Use “Tracking” if & when u smoke, read 3 “Facts.” For each 
craving read tips til u find 1 that is applicable. Do ur best to carry it out ☺ 
 
5. QuitPal! D5 activities: Use “Tracking” if & when u smoke, read 3 “Facts.” For each 
craving read tips til u find 1 that is applicable. Do ur best to carry it out. Another 
response to cravings could be watching ur recorded video & calling the featured friend 
for support ☺ 
 
6. QuitPal! D6 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” set 3 
reminders for the following week (“Reminders”). For each craving read tips til u find 
1 that is applicable. Do ur best to carry it out ☺ 
 
7. QuitPal! D7 activities: Use “Tracking” whenever u smoke, read 3 “Facts,” look over 
all ur “Tracking” entries from the previous week & take note of ur most common 
triggers. For each craving read tips til u find 1 that is applicable. Do ur best to carry it 
out ☺ 
 
8. QuitPal! D8 activities: Use “Tracking” if & when u smoke, read 3 “Facts.” Look at the 
“Summary” & “Graphs” modules & reflect on ur progress. For each craving read 
“Tips” til u find 1 that is applicable. Do ur best to carry it out. Another response to 
cravings could be watching ur recorded video & calling the featured friend for support 
☺  
 
9. QuitPal! D9 activities: Use “Tracking” if & when u smoke, read 5 “Facts.” For each 
craving read tips til u find 1 that is applicable. Do ur best to carry it out ☺ 
 
10. QuitPal! D10 activities: Use “Tracking” if & when u smoke, press the “Next” tab in 
“My Health” & read all that is listed. For each craving read tips til u find 1 that is 
applicable. Do ur best to carry it out ☺ 
 
11. QuitPal! D11 activities: Use “Tracking” if & when u smoke, read 5 “Facts,” make an 
inspirational video of urself (without deleting the previous 1). For example, u could 
mention the reasons for wanting to quit. For each craving read tips til u find 1 that is 
applicable. Do ur best to carry it out ☺ 
 
12. QuitPal! D12 activities: Use “Tracking” if & when u smoke, read 5 “Facts,” check the 
status of ur goal; if it has been met go & buy it then make a new 1. If it hasn’t been 
met, appreciate ur progress. For each craving read tips til u find 1 that is applicable. 
Do ur best to carry it out ☺ 
 
13. QuitPal! D13 activities: Use “Tracking” if & when u smoke, read 5 “Facts,” set 3 new 
“Reminders.” For each craving read tips til u find 1 that is applicable. Do ur best to 
carry it out ☺ 
 
14. QuitPal! D14 activities: Use “Tracking” if & when u smoke, read 5 “Facts,” look over 
all ur “Tracking” entries from the previous week & take note of ur most common 
triggers, also consider if these are different from the previous week. For each craving 
read tips til u find 1 that is applicable. Do ur best to carry it out ☺ 
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15. QuitPal! D15 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” look at 
“Summary” & “Graphs” & reflect on ur progress. For each craving read tips til u find 
1 that is applicable. Do ur best to carry it out. Another response to a craving could be 
watching ur recorded videos & calling the featured friend from the first for support ☺ 
 
16. QuitPal! D16 activities: Use “Tracking” if & when u smoke, read 3 “Facts.” For each 
craving read tips til u find 1 that is applicable. Do ur best to carry it out ☺ 
 
17. QuitPal! D17 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” make an 
inspirational video of someone new (keep the old ones). For each craving read tips til 
u find 1 that is applicable. Do ur best to carry it out ☺ 
  
18. QuitPal! D18 activities: Use “Tracking” if & when u smoke, read 3 “Facts,” press the 
“Next” tab in “My Health” & read all. For each craving read tips til u find 1 that is 
applicable. Do ur best to carry it out ☺ 
 
19. QuitPal! D19 activities: Use “Tracking” if & when u smoke, read 3 “Facts.” For each 
craving read tips til u find 1 that is applicable. Do ur best to carry it out ☺ 
 
20. QuitPal! D20 activities: Use “Tracking” if & when u smoke, look at “Summary” & 
“Graphs” & reflect on ur progress, read 3 “Facts.” For each craving read tips til u find 
1 that is applicable. Do ur best to carry it out. Another response to cravings could be 
watching ur recorded videos & calling the featured friends from the first &/or third for 
support ☺ 
 
21. QuitPal! D21 activities: Look over the last week of “Tracking” entries & consider 
what ur most common triggers are (& if they differ from previous wks), read 3 
“Facts.” For each craving read “Tips” til u find 1 that is applicable. Do ur best to carry 
it out. Make a new inspirational video, congratulating urself on ur progress & briefly 
list the key “Tips” that will keep u smoke-free ☺ 
 
22. Congratulations on making it to Day 22 of QuitPal! Today’s activities: Watch the 
video that u made yesterday & continue to use the QuitPal tools as needed. Good-luck 
with staying smoke-free ☺ 
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7.9.3 QuitPal handout 
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7.10 Appendix J. ERP graphs 
7.10.1 Baseline ERPs 
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Figure 7.2. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at FZ elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
Figure 7.3. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at F1 elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.4. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at F2 elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.5. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at FCZ elicited 
during the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking 
(pink), unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.6. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at CZ elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.7. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at CPZ elicited 
during the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking 
(pink), unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.8. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at PZ elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.9. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at P1 elicited during 
the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking (pink), 
unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.10. Baseline grand-average ERPs of 12 NS (left) and 37 S (right) at P2 elicited 
during the image slideshow. Picture categories: neutral (navy), pleasant (light blue), smoking 
(pink), unpleasant (red). Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.11. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at FZ elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.12. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at F1 elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.13. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at F2 elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.14. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at FCZ elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
Figure 7.15. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at CZ elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.16. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at C1 elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
Figure 7.17. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at C2 elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.18. Baseline grand-average ERPs of 11 NS (left) and 37 S (right) at CPZ elicited 
during the Go/NoGo task, showing Go (red) and NoGo (navy) stimuli. Vertical grey line 
marks stimulus onset (i.e., 0 ms). 
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Figure 7.19. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at FZ elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.20. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at F1 elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.21. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at F2 elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.22. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at FCZ elicited during the image slideshow. Picture categories: 
neutral (navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line 
marks stimulus onset. 
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Figure 7.23. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at CZ elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.24. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at CPZ elicited during the image slideshow. Picture categories: 
neutral (navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line 
marks stimulus onset. 
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Figure 7.25. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at PZ elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.26. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at P1 elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.27. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at P2 elicited during the image slideshow. Picture categories: neutral 
(navy), pleasant (light blue), smoking (pink), unpleasant (red). Vertical grey line marks 
stimulus onset. 
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Figure 7.28. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at FZ elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.29. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at F1 elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.31. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at FCZ elicited during the Go/NoGo task, showing Go (red) and 
NoGo (navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.30. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at F2 elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.32. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at CZ elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
Figure 7.33. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at C1 elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.34. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at C2 elicited during the Go/NoGo task, showing Go (red) and NoGo 
(navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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Figure 7.35. Baseline grand-average ERPs of 11 NS (left) and 11 S (right) at baseline (top) 
and follow-up (bottom) at CPZ elicited during the Go/NoGo task, showing Go (red) and 
NoGo (navy) stimuli. Vertical grey line marks stimulus onset (i.e., 0 ms). 
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